Deep Intelligence Across Industries

The Estée Lauder Companies is the world's largest pure-play prestige beauty house. It owns a portfolio of more than 20 luxury and prestige brands, including Estée Lauder, Clinique, M·A·C, La Mer, Jo Malone London, TOM FORD, Le Labo and The Ordinary, sold in about 150 countries. Skin care (about 49% of FY2026 sales) anchors the profit pool, and luxury fragrance is now the fastest-growing engine. FY2023–FY2025 were three years of decline. Over-exposure to Chinese consumers and Asia travel retail unwound, the company took $1.3B of impairments, and it posted a $1.1B net loss in FY2025. FY2026 was the first year of the "Beauty Reimagined" turnaround under CEO Stéphane de La Faverie: organic sales rose 3% and adjusted operating margin expanded 320bp to 11.2%. The investment case now depends on restoring scale growth in North America, sustaining China share gains, and converting $1.2B of restructuring benefits into a "solid double-digit" margin. Family control (82% of votes) limits governance optionality. The abandoned Puig merger in 2026 showed the board is willing to consider transformative M&A. --- **Company's own description (10-K FY2026, paraphrased).** The company describes itself as one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and as a steward of more than 20 luxury and prestige brands. It operates mainly as a wholesaler. Its products are sold in physical stores and on e-commerce platforms run by department stores, duty-free retailers, specialty-multi retailers, online pure players, perfumeries and pharmacies, and salons and spas. It also runs a direct-to-consumer business through freestanding stores, brand websites and third-party online platforms. Since February 2025 its strategic vision has been "Beauty Reimagined", executed through the "One ELC" operating model. **Independent characterization.** EL is a brand-portfolio owner and marketer that is vertically integrated into formulation and manufacturing. It sits at the top of the beauty value chain: - It controls R&D, brand equity and most manufacturing. It has its own plants in the US, Canada, Belgium, Switzerland, the UK and Japan, plus third-party manufacturers. - Downstream it relies heavily on retail partners. Its revenue model is about 99% product sales. Royalty income, mainly from licensing the TOM FORD fashion and eyewear trademark, sits in "Other" (about $103M in FY2026, 0.7% of sales). There is no meaningful subscription or service revenue. - Price architecture runs from accessible-prestige (The Ordinary) to ultra-luxury (La Mer, TOM FORD Private Blend, Frédéric Malle). **Customer types.** - Retail customers (B2B): department stores such as Macy's, Nordstrom and Harrods; specialty-multi retailers such as Sephora, Ulta and Douglas; duty-free operators in Hainan, Korea and Hong Kong; e-commerce platforms such as Tmall, JD.com and Amazon Premium Beauty; TikTok Shop; perfumeries and pharmacies; and salons (Aveda, Bumble and bumble). - End consumers (B2C) through freestanding stores and brand.com sites. - Licensees (TOM FORD fashion and eyewear), which generate royalty income. **End-markets.** The company serves global prestige skin care, color cosmetics, fine fragrance (including the fast-growing "artisanal/niche" luxury tier) and professional or prestige hair care. - By geography, about 26% of FY2025 net sales were in the US and 74% international (FY2025 Fact Sheet). - Mainland China alone was $3.06B, or 20% of FY2026 net sales. - Travel retail, now reported inside Asia/Pacific, was about 15% of reported sales in FY2025, down sharply from its pandemic-era peak (BeautyMatter, FY2025 call). **Seasonality.** First-half (July–December) sales are typically slightly higher than the second half because of holiday and key shopping events such as 11.11 and 6.18 in China (10-K FY2026).

FMC Corporation is a Philadelphia-based, pure-play crop-protection company and one of the tier-one research-based agrochemical innovators, alongside Syngenta, Bayer, BASF and Corteva. It discovers, develops, manufactures and markets insecticides, herbicides, fungicides and "Plant Health" products (biologicals, crop nutrition, seed treatment) through distributors, retailers, cooperatives and, increasingly, direct-to-grower channels in Brazil. Its economic franchise was built on the diamide insecticides acquired from DuPont in 2017: Rynaxypyr® (~USD 0.8bn of FY2025 sales) and Cyazypyr® (~USD 0.4bn). Both have now lost core patent protection. FMC is therefore in a deep transition. FY2025 revenue fell to USD 3.47bn and the company booked a USD 2.24bn GAAP loss. It has cut the dividend 86%, fallen to junk credit status, and in 2026 raised capital through asset sales, a Corteva licence and a 20% equity stake sale to Tessenderlo Group. The equity case now rests on four new-mode-of-action active ingredients: Isoflex®, fluindapyr, Dodhylex™ and rimisoxafen. --- ### Company's own description (FY2025 10-K, paraphrased) FMC describes itself as a global agricultural sciences company that supplies farmers with innovative solutions to increase the productivity and resilience of their land, and states that it operates in a single business segment. It develops, markets and sells all three major classes of crop-protection chemicals (insecticides, herbicides and fungicides), together with biologicals, crop nutrition and seed-treatment products grouped as "Plant Health." The 10-K calls FMC a "tier-one leader" in agrochemicals, positioned through technology, geographic balance and crop diversity. For 2026 it sets four operational priorities: - strengthening the balance sheet; - improving competitiveness of the core portfolio; - managing the post-patent Rynaxypyr® transition; - supporting the growth of new active ingredients. ### Business model and revenue model | Dimension | Characterization | Evidence | |---|---|---| | Revenue model | Overwhelmingly product sales of formulated crop-protection products and active ingredients (AIs) | 10-K FY2025 product table | | Service revenue | Immaterial; Arc™ farm intelligence (precision-ag platform) is a commercial support tool, not a disclosed revenue line | 10-K FY2025 | | Licensing / supply revenue | Growing: cost-plus diamide supply to partners; Albaugh licence on chlorantraniliprole process (Nov 2024); Corteva rimisoxafen co-exclusive supply and licence with a USD 200M prepayment (Jun 2026); India supply agreement with Crystal Crop on close | 10-K FY2025; Q4 FY2025 release; 10-Q Q2 FY2026 | | Subscription | None disclosed | — | | Product mix (FY2023, latest disclosed split) | Insecticides ~59%, herbicides ~29%, fungicides ~7%, Plant Health ~4%, other ~1% | 2023 Corporate Fact Sheet (label mapping inferred from chart) | | Portfolio framing | "Core" portfolio = Rynaxypyr® plus legacy off-patent herbicides and insecticides. "Growth" portfolio = Cyazypyr®, the four new AIs and Plant Health | Q4 FY2024 release footnote; 10-K FY2025 | ### Value-chain position FMC is a discovery-to-formulation innovator that relies heavily on outsourcing. It owns large-scale AI plants in: - Mobile, Alabama (USA) - Manati, Puerto Rico - Jinshan, China - Rønland, Denmark - Panoli, India It also sources "critical intermediates and finished products" largely from third parties in China and India (10-K FY2025 risk factors). Downstream, it sells through: - distributors, retailers and cooperatives in all four regions; - direct sales to large growers in Brazil, an expanding channel cited as a Q4 FY2026 growth driver; - alliance partners, including diamide partners on "cost-plus" contracts. ### Customer types and end-markets Customers are agricultural distributors and retailers, co-ops, large growers (Brazil), and other agrochemical companies that buy diamide AI under supply contracts. End-markets are row crops (soybean, corn, cotton, sugarcane, rice, cereals) and specialty crops (fruits, vegetables, tree nuts). Non-crop uses (pest control, turf) were largely exited with the sale of the Global Specialty Solutions business in November 2024. Demand is seasonal. Northern-hemisphere demand runs March–September, weighting Q1/Q2. Southern-hemisphere demand runs July–February, weighting Q3, Q4 and Q1 (10-K FY2025). ### Independent characterization FMC is a mid-sized research-based agrochemical company. It has a disproportionately concentrated franchise: the diamides were roughly 35% of FY2025 GAAP revenue (USD ~1.2bn of USD 3.47bn). The company is now caught between generic-driven price deflation on its legacy molecules and a still-sub-scale new-AI portfolio (USD ~200M in FY2025). It also faces an unusually leveraged balance sheet for a company of its size. Its strategy has shifted from "growth and returns" (2021–2023) to "survival and re-base" (2025–2026): - monetize IP through partners (Corteva); - shrink the manufacturing footprint (Project Foundation); - exit structurally unprofitable markets (India commercial); - recapitalize via a strategic minority investor (Tessenderlo).

Sappi is a mid-sized, vertically integrated woodfibre group with operations on three continents and sales into more than 150 countries. Its earnings rest on two structurally different engines. The first is a globally significant dissolving wood pulp (DWP) franchise, Verve, based in South Africa and Cloquet (US), backed by company-owned plantations; in FY2025 it generated 46% of group Adjusted EBITDA from 29% of volumes. The second is a portfolio of graphic, packaging and speciality papers in Europe and North America. Since 2021 management has pursued a portfolio pivot: shrinking European graphic paper through closures and now a 50/50 joint venture with UPM, and redeploying capital into US solid bleached sulphate (SBS) paperboard through the US$418m Somerset PM2 conversion. The investment cycle peaked into a severe pricing downturn. As a result, Sappi enters FY2027 highly levered (6.5x net debt/Adjusted EBITDA at June 2026), with covenant testing suspended to March 2027 and a regulatory-dependent restructuring of Europe pending. --- **Company's own description.** The latest reporting describes the group in one line: "Sappi uses renewable resources to make woodfibre-based products." [S4, FY2026]. Management further describes Sappi as a diversified, innovative and trusted leader making pulp, packaging and speciality papers, graphic papers and biomaterials from woodfibre sourced from sustainably managed forests. Many mills are energy self-sufficient through internally generated bioenergy [S4]. **What the company does.** Sappi converts wood (largely its own plantation fibre in South Africa, plus purchased wood in Europe and North America) into three main product families: 1. **Pulp.** This comprises dissolving wood pulp sold mainly to viscose staple fibre (VSF) and other cellulose-derivative producers (textiles, plus pharmaceutical and food applications), together with paper-grade and high-yield pulp (BCTMP) used internally or sold externally [S3][S9]. 2. **Packaging and speciality papers (P&SP).** This includes SBS/solid bleached board paperboard, label papers, flexible packaging papers, release papers (casting/release for synthetic leather and laminates), containerboard (South Africa), tissue and technical papers [S3][S9]. 3. **Graphic papers.** These are coated woodfree, coated mechanical, uncoated woodfree office paper and newsprint [S3][S9]. Biomaterials (nanocellulose, lignin, xylose, furfural) and forestry/timber sales round out the portfolio [S9]. **Business model.** The model is overwhelmingly product sales. There is no material service, subscription or licensing revenue disclosed. Revenue is booked on delivery of tonnes. Since FY2025, revenue has been presented net of delivery costs where Sappi acts as agent for shipping; FY2024 was restated accordingly [S3]. **Value-chain position.** Sappi is upstream-integrated from forest to pulp to paper in South Africa, with 401,000 ha owned or leased, of which 262,000 ha is planted [S9; date of figure not stated]. It is partially integrated in North America (Cloquet pulp to graphic paper; Matane BCTMP to Somerset board) and in Europe (Ehingen, Gratkorn and Kirkniemi pulp lines). It sells mainly B2B to converters, printers, merchants, VSF/textile mills, label converters, packaging converters and brand owners. **Independent characterisation.** Despite revenue still being about 44% graphic paper, Sappi should be analysed as a DWP-and-packaging group carrying a large, declining graphic-paper tail. The economics are highly asymmetric: **Pulp:** is the profit engine: 46% of FY2025 Adjusted EBITDA from 29% of volumes [Sappi investor page, FY2025]. **P&SP:** has absorbed most recent capital but delivered only 13% of FY2025 Adjusted EBITDA from 30% of volumes. In 9M FY2026 its Adjusted EBITDA was slightly negative [S3][S4]. **Graphic paper:** remains cash-generative in North America, where supply is tight after the PM2 conversion and import tariffs. It is structurally loss-prone in Europe [S3][S4]. **Value drivers to watch:** the CCF hardwood DWP price in China, the ZAR/US$ exchange rate, which drives South African margins and plantation valuations, and NA SBS paperboard pricing. **Customer types and end-markets:** - Textile and nonwoven fibre producers (VSF, lyocell), mainly in Asia - Food, beverage, cosmetics and pharma brand owners (via label and packaging converters) - Commercial printers, publishers and catalogue/magazine producers - Office paper distributors and newspaper publishers (South Africa) - Agricultural exporters (citrus containerboard in South Africa) - Automotive, fashion and decorative-laminate producers (release paper) - Industrial users of lignin and biochemicals

NIKE, Inc. is the world's largest designer, marketer and distributor of athletic footwear, apparel and equipment, operating three brands — NIKE, Jordan and Converse — across substantially every country on earth through a hybrid model of wholesale distribution and owned direct-to-consumer channels. It is an asset-light brand company: nearly all product is made by independent contract manufacturers concentrated in Vietnam, Indonesia, China and Cambodia, while NIKE retains design, innovation, marketing, demand creation and marketplace control. Its competitive position rests on the most valuable trademark portfolio in sport, unmatched athlete and league endorsement infrastructure, and scale economics that no competitor approaches. As of FY2026 the company is mid-way through the most significant strategic reset in two decades: a shift back from a digitally-led direct model toward an integrated, wholesale-inclusive marketplace, and a reorganisation from consumer-gender categories to vertically-integrated sport teams under an operating model management calls "Sport Offense." Revenue has been flat to declining for three years and the equity has de-rated severely. *FY2024 headcount of approximately 79,400 is the figure disclosed in NIKE's FY2024 Form 10-K and widely cited thereafter. The FY2026 figure of approximately 73,000 is stated directly in the FY2026 Form 10-K.* --- ## The company's own description In the FY2026 Form 10-K, NIKE describes its principal business activity as the design, development and worldwide marketing and selling of athletic footwear, apparel, equipment, accessories and services, and states plainly that it is the largest seller of athletic footwear and apparel in the world. It sells through NIKE Direct operations — comprising NIKE-owned retail stores and digital platforms referred to as NIKE Brand Digital — and to wholesale accounts including independent distributors, licensees and sales representatives in nearly all countries. It also offers interactive consumer services and experiences. Nearly all products are manufactured by independent contractors, and nearly all footwear, apparel and equipment is manufactured outside the United States. The 10-K articulates the strategy as achieving sustainable, profitable long-term growth by leading with sport, creating innovative "must-have" products, building deep personal consumer connections with the brands, and delivering compelling consumer experiences through digital platforms and at retail. ## Independent characterisation NIKE is best understood as three overlapping businesses operating under one balance sheet. **First, a branded product design and licensing engine.** The economic core of NIKE is not manufacturing — it owns almost no finished-goods factories — but the ownership and continuous refreshment of trademarks (NIKE, Swoosh, Jumpman, Air Max, Chuck Taylor) and the technology platforms (Air, Zoom, ZoomX, Flyknit, Dri-FIT, React, FlyEase) that justify a price premium over commodity footwear. Gross margin of 42.9% in FY2026 is the visible output of this: the difference between contract-manufactured cost and brand-supported retail price. **Second, a wholesale distribution business.** In FY2026, wholesale revenue was 27.5 billion USD, approximately 59% of total company revenue, and grew 6% reported / 4% currency-neutral even as the total shrank. This is the channel NIKE deliberately de-emphasised between 2017 and 2023 and has spent the last two fiscal years rebuilding. It is lower-gross-margin but lower-fixed-cost and lower-working-capital than direct retail. **Third, an owned retail and digital business.** NIKE Direct generated 17.7 billion USD in FY2026 (approximately 38% of total revenue), split between NIKE Brand Digital at 8.6 billion USD and NIKE-owned stores at 9.1 billion USD. This is the part of the business in structural retreat: digital fell 12% and comparable store sales fell 4% in FY2026. It carries high fixed costs — leases, store labour, technology platforms — which is why its decline is disproportionately painful to operating leverage. ## Revenue model composition | Revenue stream (USD M) | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Wholesale (NIKE Brand) | n/d | 25943 | 27500 | | NIKE Direct total | n/d | 18800 | 17700 | | NIKE Brand Digital | n/d | 9600 | 8600 | | NIKE-owned stores | n/d | 9200 | 9100 | | Global Brand Divisions (licensing and other) | 45 | 48 | 49 | | Converse | 2082 | 1692 | 1174 | NIKE is overwhelmingly a product company. There is no meaningful subscription revenue line. Licensing and miscellaneous non-geographic revenue is reported within "Global Brand Divisions" and totalled just 49 million USD in FY2026 — a rounding error at 0.1% of revenue — although this understates the economic role of licensing, since licensed team and league apparel sold by NIKE itself is booked in the geographic segments. *FY2025 wholesale of approximately 25.9 billion USD is derived from the FY2026 disclosure that wholesale grew 6% on a reported basis to 27.5 billion USD; NIKE Direct FY2025 of 18.8 billion USD is stated directly in the FY2026 10-K MD&A. FY2024 channel splits are not restated in the FY2026 filing and are marked n/d.* ## Value chain position and customer types NIKE occupies the design–brand–marketing tier of the athletic goods value chain and outsources both upstream materials conversion and a majority of downstream physical retail. Its direct customers fall into four groups: (i) large multi-brand athletic retailers (Foot Locker, JD Sports, Dick's Sporting Goods and equivalents); (ii) department and specialty stores; (iii) international independent distributors and licensees in markets where NIKE does not operate directly; and (iv) end consumers via NIKE Direct. In FY2026, no single customer accounted for 10% or more of consolidated revenues, but NIKE's three largest U.S. customers accounted for approximately 29% of U.S. sales, and its three largest non-U.S. customers accounted for approximately 16% of non-U.S. sales — a meaningful concentration that has increased as retail has consolidated. ## End markets Performance athletic footwear and apparel (running, basketball, global football, training, tennis, golf, skateboarding, outdoor/ACG); lifestyle and streetwear derived from athletic heritage (Sportswear, Jordan streetwear, Converse); and licensed team/league apparel. Geographically the business is roughly 44% United States and 56% international by revenue in FY2026 — a U.S. weighting that has risen for two consecutive years as international, and particularly Greater China, has contracted.

DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).

HCLTech is the third-largest India-headquartered IT services company by revenue and the only one of its scale that operates a genuine, owned enterprise software products business alongside services. Its FY2026 revenue of $14.66 billion divides into roughly 91% services — split between IT and Business Services and Engineering and R&D Services — and 9.5% HCLSoftware, a portfolio assembled largely from IBM's divested product estate and the Actian data platform. That structural asymmetry is the company's defining feature: it produces a software segment earning 26.5% EBIT margins and $1.05 billion of annual recurring revenue, an engineering business with genuine German and aerospace depth, and an infrastructure services franchise built on the remote-infrastructure-management model HCL itself pioneered. The trade-off is a blended EBIT margin of 17.2%, structurally below Tata Consultancy Services and Infosys. Management is now betting the next cycle on "Advanced AI", which reached a $620 million annualised run-rate by the fourth quarter of FY2026. | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Total headcount at fiscal year end | 227500 | 223420 | 227181 | | Net headcount addition during the year | n/a | -4080 | 3761 | | Freshers added during the year | n/a | n/a | 11744 | | LTM attrition (%) | n/a | 13.0 | 12.5 | | Women in workforce (%) | n/a | 28.8 | 29.6 | The FY2024 closing headcount is derived, not directly cited: management stated on the FY25 earnings call that the employee base shrank 1.8% during FY2025 while revenue grew 4.7%, which implies a 31 March 2024 base of approximately 227,500. The three-year arc is unusual and analytically important: HCLTech grew revenue by roughly 10.5% in USD across FY24–FY26 while ending the period with essentially the same number of people it had at the start. Revenue per employee reached $65,500 per annum in Q1 FY2027, up 3.3% year on year. --- ### The company's own description HCLTech describes itself, in the boilerplate appended to every FY2026 and Q1 FY2027 release, as a global technology company with more than 223,000 people across 60 countries, delivering capabilities centred on AI, digital, engineering, cloud and software, powered by a broad portfolio of technology services and products. It states that it works with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Semiconductor, Telecom and Media, Retail and CPG, Mobility and Public Services. The FY2025 Annual Report characterises the ITBS segment as enabling global enterprises to drive agile, sustainable business transformation that enhances client and employee experiences, and describes it as the most significant contributor to the revenue mix. HCLSoftware is described in the same document as one of the largest enterprise software product businesses headquartered out of Asia, built on a legacy of product heritage, innovation and engineering excellence. ### Independent characterisation HCLTech is best understood not as a single business but as three businesses of very different economic character sharing a delivery workforce, a client list and a balance sheet. **The first is a large-scale IT and business services franchise** (73.8% of FY2026 revenue). Its historical differentiator — and the origin of the entire company's modern shape — is infrastructure management. The remote infrastructure management proposition was built inside HCL Comnet in the mid-1990s by a team that included the current CEO, and it took share directly from EDS, CSC and IBM Global Services. HCLTech's own executive biographies state that this business now contributes approximately $5 billion of the group's revenue. Around that core the company has layered application services, enterprise applications (SAP, Oracle, ServiceNow, Salesforce), data and AI, cybersecurity, digital workplace, networks and digital process operations. Economically this is a labour-arbitrage-plus-automation business: revenue is recognised on time-and-materials and managed-services contracts, backlog is expressed as total contract value, and margin is a function of pyramid shape, utilisation, offshore mix and automation intensity. It earned a 16.0% EBIT margin in FY2026. **The second is Engineering and R&D Services** (17.0% of FY2026 revenue), which HCLTech operates at a scale few peers match. This business sells to clients' R&D budgets rather than their IT budgets — semiconductor physical design and VLSI, embedded firmware, aerospace certification and technical publications, medical device engineering, automotive software, and product engineering for software and internet companies. It is anchored by the ASAP Group in Germany (automotive engineering consulting) and Butler Aerospace in the United States (a Special Security Agreement entity serving classified US defence work). ERS grew 9.8% in constant currency in FY2026 — comfortably the fastest-growing of the three segments — at a 16.8% EBIT margin. **The third is HCLSoftware** (9.5% of FY2026 revenue, before intersegment elimination), a genuine software products business with its own president, its own revenue architecture and its own margin profile. Its revenue model is disclosed in three lines: perpetual licence upfront and compliance revenue ($127M in FY26), subscription and support including SaaS ($1,190M), and professional services ($78M). Annual recurring revenue was $1,045 million at 31 March 2026. This is the segment that gives HCLTech a claim no other large Indian IT firm can make — but it is also the segment currently contracting, down 4.1% in constant currency in FY2026. ### Revenue model composition (FY2026) | Revenue type | Approximate share of group revenue | Basis | |---|---|---| | Services (time-and-materials, managed services, outcome-based) | 90.8% | Disclosed segment mix | | Software subscription, support and SaaS | 8.1% | $1,190M of $14,664M | | Software perpetual licence and compliance | 0.9% | $127M of $14,664M | | Software-attached professional services | 0.5% | $78M of $14,664M | | Intersegment elimination | -0.3% | Disclosed | ### Value chain position, customers and end markets HCLTech sits between the technology producers (hyperscalers, semiconductor firms, software vendors, network equipment makers) and the enterprises that consume technology. It monetises both directions: it is an implementation and managed-services channel for AWS, Microsoft, Google, NVIDIA, OpenAI, ServiceNow, SAP, Salesforce, Red Hat, Intel, Lenovo, HPE and IBM; and it is an engineering supplier *to* those same producers, which is why "Technology and Services" is now HCLTech's third-largest and fastest-growing vertical at 14.3% of services revenue and 15.0% constant-currency growth in FY2026. Customers are large enterprises. At 31 March 2026 the company reported 23 clients each generating more than $100 million of trailing-twelve-month revenue, 60 above $50 million, and 976 above $1 million. Client concentration is low and falling: the top five accounts were 11.9% of revenue (down from 12.7% a year earlier), the top ten 19.1%, and the top twenty 28.5%. End markets served, by disclosed vertical, are Financial Services (banking, capital markets, insurance, fintech); Manufacturing; Technology and Services; Life Sciences and Healthcare; Telecommunications, Media, Publishing and Entertainment; Retail and Consumer Packaged Goods; and Public Services (which HCLTech defines as including Energy and Utilities, Travel–Transport–Logistics and Government). Aerospace and Defense, Semiconductor, Mining and Natural Resources, Oil and Gas, and Private Equity are additionally maintained as distinct go-to-market industry practices.

RTX occupies a structurally advantaged position that no other prime replicates: roughly half its revenue is commercial aerospace and half defence, giving it a natural hedge across two cycles that rarely peak together — and which, unusually, are peaking together in 2026. Collins Aerospace and Pratt & Whitney are entrenched on the installed base of the global narrowbody and widebody fleet, generating decades-long, high-margin aftermarket annuities. The Raytheon segment is the Western world's dominant supplier of ground-based air and missile defence effectors — Patriot, GEM-T, AMRAAM, Standard Missile, ESSM — precisely the munitions category that European rearmament and Middle East conflict have made scarce. A record $289 billion backlog at 30 June 2026, equal to roughly three years of sales, converts that positional advantage into unusual revenue visibility. The offsetting reality is that RTX carries $37 billion of debt, an $85 billion goodwill-and-intangible balance from the merger, and the unresolved cost tail of the GTF powder-metal remediation. RTX Corporation is the world's largest aerospace and defence company by revenue, and the only prime contractor that simultaneously holds franchise positions in commercial aircraft engines, commercial aerospace systems, and ground- and sea-based integrated air and missile defence. It was created in April 2020 by the merger of Raytheon Company with the aerospace businesses of United Technologies Corporation, and it renamed itself from Raytheon Technologies to RTX in July 2023 alongside a consolidation from four operating segments to three. --- ### What the company does RTX designs, manufactures, and services aerospace and defence systems for commercial airlines, aircraft OEMs, business aviation operators, the U.S. Government (principally the Department of Defense, latterly styled the Department of War in contract announcements), and allied governments worldwide. Its FY2025 Form 10-K describes the three segments as follows: Collins Aerospace provides advanced aerospace and defence products; Pratt & Whitney supplies aircraft engines; and Raytheon delivers defensive and offensive threat detection and mitigation capabilities. The company's independent characterisation is better expressed as three distinct economic engines bolted onto one balance sheet: 1. **An installed-base annuity business (Pratt & Whitney and, to a lesser degree, Collins).** Engines and nacelles are sold at or near cost — sometimes at a loss — to win position on an airframe, after which spare parts, overhauls, and long-term service agreements generate profit for twenty to thirty years. This is why Pratt & Whitney's reported segment margin (8.3% in FY2025) looks weak against Collins (16.2%) despite comparable revenue: Pratt is still absorbing original-equipment loss content on the GTF ramp while the aftermarket annuity has yet to reach maturity. 2. **A cost-plus and fixed-price government contracting business (Raytheon, plus Collins' defence lines).** Revenue is recognised over time on the percentage-of-completion basis, which makes reported margins highly sensitive to estimate-at-completion revisions. The FY2024 $575 million charge on a terminated foreign fixed-price development contract is the canonical illustration. 3. **A component and systems supply business (Collins).** Avionics, interiors, power management, and aerostructures sold to Airbus, Boeing, Embraer, Bombardier, and defence primes, with a large parts-and-repair aftermarket layered on top. ### Revenue model and mix | Metric | FY2025 | |---|---| | Commercial share of sales | 48% | | Defence share of sales | 52% | | Products share of sales | ~74% | | Services share of sales | ~26% | | Sales to U.S. Government (excl. FMS) | $33,279m (38% of net sales) | | Total international sales | $41,312m (47% of net sales) | | Total backlog | $268bn ($161bn commercial / $107bn defence) | | Backlog expected to convert within 12 months | ~25% | Sources: FY2025 Form 10-K Item 1 (U.S. government and international sales tables, backlog); RTX 2025 Annual Report sales-mix infographic; Q3 2025 disclosure for the product/service split. Note the structural shift: U.S. Government sales fell from 46% of revenue in FY2023 to 38% in FY2025 — not because U.S. volume declined (it rose from $31.6bn to $33.3bn) but because international and commercial revenue grew far faster. This is the single most important mix fact in the company today, because international direct commercial sales carry materially better margins than U.S. cost-type work, and because European air-defence procurement is the fastest-growing pool RTX addresses. ### Value chain position and customers RTX sits at the prime and Tier-1 layers simultaneously. On F-35 it is a major subsystem supplier (F135 propulsion via Pratt; sensors and avionics via Collins) to prime contractor Lockheed Martin — a direct competitor at the enterprise level. On Patriot and SPY-6 it is the prime. On A320neo it is a propulsion and nacelle supplier to Airbus, which in March 2026 was reported to be formally seeking damages from Pratt & Whitney over GTF disruption. This simultaneous supplier/competitor/counterparty posture across the same customer set is a defining feature of RTX's commercial relationships and a recurring source of litigation and negotiation risk. **End-markets served:** commercial air transport (OE and aftermarket); regional and business aviation; rotorcraft; military fixed-wing and rotary propulsion; integrated air and missile defence; naval combat systems; precision-guided munitions; space sensing and communications; airport and airline IT infrastructure; and government training and mission services.

Charles Schwab is the scale utility of American retail investing. Fifty-five years after it helped invent discount brokerage, it sits at the intersection of four businesses that most competitors run separately: a self-clearing broker-dealer, a savings-and-loan holding company with three chartered banks, an asset manager, and the largest custodian for independent registered investment advisors. That combination is the whole thesis. Client cash swept into Schwab's banks funds an interest-earning balance sheet; client assets generate management and administration fees; client engagement generates trading revenue; and the same platform serves both channels, spreading fixed costs across USD 13.08 trillion of client assets and 48.0 million accounts as of 30 June 2026. Management estimates U.S. investable wealth exceeds USD 80 trillion, framing Schwab's roughly 15% share as an incumbency rather than a ceiling. The model's strength — and its principal vulnerability — is that revenue is levered to interest rates, market levels, and client cash behaviour, none of which Schwab controls. --- ### The company's own description The FY2025 Form 10-K states that CSC "is a savings and loan holding company" that "engages, through its subsidiaries, in wealth management, securities brokerage, banking, asset management, custody, and financial advisory services." At 31 December 2025 the company reported USD 11.90 trillion in client assets, 38.5 million active brokerage accounts, 5.7 million workplace plan participant accounts, and 2.2 million banking accounts. The three principal operating subsidiaries named in the 10-K are Charles Schwab & Co., Inc. (CS&Co), a securities broker-dealer incorporated in 1971; Charles Schwab Bank, SSB (CSB), the principal banking entity; and Charles Schwab Investment Management, Inc. (CSIM), investment advisor to the proprietary Schwab Funds and Schwab ETFs. Two further depository institutions — Charles Schwab Premier Bank, SSB (CSPB) and Charles Schwab Trust Bank — are Texas- and Nevada-chartered savings banks respectively. Charles Schwab Futures and Forex LLC (CSFF) is registered as a futures commission merchant and forex dealer member with the CFTC. Management's stated strategy is described in the filings as "Through Clients' Eyes," summarised in the 2026 proxy as offering a broad product range "with a focus on transparency, value, service, and trust," combining scale with expense discipline, and building stockholder value over time. ### Independent characterisation Schwab is not primarily a brokerage in economic terms; it is a spread lender wrapped in a distribution franchise. In FY2025 net interest revenue of USD 11,750 million represented 49.1% of total net revenues, and in the first half of FY2026 net interest revenue of USD 6,501 million represented 48.0%. The company's principal funding source is uninvested client cash — a liability it obtains at an average rate of 0.19% on bank deposits in Q2 2026 — deployed into securities, margin receivables, and bank loans yielding 3.47% on average. That spread, not commissions, is the profit engine. The distribution franchise makes the funding cheap and sticky. Because clients hold assets at Schwab for custody, advice, trading, and banking, the cash balance is a by-product of a relationship rather than a rate-shopped deposit. This is why the 10-K identifies "Operating Structure — Providing bank, wealth, and asset management services to broker-dealer clients" as a stated competitive advantage. ### Revenue model composition | Revenue line | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Interest revenue (gross) | nd | 15537 | 15504 | | Interest expense | nd | -6393 | -3754 | | Net interest revenue | 9427 | 9144 | 11750 | | Asset management and administration fees | 4756 | 5716 | 6506 | | Trading revenue | 3230 | 3264 | 3921 | | Bank deposit account fees | 705 | 729 | 977 | | Other revenue | 719 | 753 | 767 | | Total net revenues | 18837 | 19606 | 23921 | | Revenue line | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Net interest revenue (% of total) | 50.0 | 46.6 | 49.1 | | Asset management and administration fees (% of total) | 25.2 | 29.2 | 27.2 | | Trading revenue (% of total) | 17.1 | 16.6 | 16.4 | | Bank deposit account fees (% of total) | 3.7 | 3.7 | 4.1 | | Other revenue (% of total) | 3.8 | 3.8 | 3.2 | Schwab reports four principal revenue lines plus "other." The mix is a useful map of the business model: roughly half spread income, a quarter recurring asset-based fees, a sixth transactional, and the remainder off-balance-sheet deposit fees and miscellaneous items. **Revenue by category (USD millions)** **Revenue mix as percentage of total net revenues** There is no subscription or licensing revenue of material scale. Bank deposit account fees are earned under the Second Amended and Restated Insured Deposit Account Agreement (the "2023 IDA agreement") with TD Bank USA, N.A. and TD Bank, N.A., under which eligible uninvested client cash is swept off balance sheet to deposit accounts at those institutions and Schwab receives recordkeeping and support fees. ### Value chain position, customers, and end-markets Schwab occupies the custody-and-distribution layer of the U.S. wealth value chain. It manufactures proprietary product (Schwab Funds, Schwab ETFs, collective trust funds, managed portfolio strategies), distributes third-party product (Mutual Fund Marketplace, third-party ETFs, alternative investments), and provides the plumbing (self-clearing, custody, settlement, banking, trust). Customer types are three: (i) individual retail investors from beginners to ultra-high-net-worth, served through the Investor Services segment; (ii) employers and their employees, served through Workplace Services within Investor Services; and (iii) independent registered investment advisors, independent retirement advisors, and recordkeepers, served through the Advisor Services segment. RIAs are notable because Schwab charges them no custody fee — the economics are earned on the underlying client assets through spread and asset-based fees. End-markets served are essentially domestic. The 10-K describes more than 380 domestic branch offices across 48 states and the District of Columbia, plus locations in Puerto Rico, the United Kingdom, Hong Kong, and Singapore. Cross-jurisdictional activity at 31 December 2025 was approximately USD 31 billion against total consolidated assets of approximately USD 491 billion — under 7%.

| Field | Detail | |---|---| | Entity profiled | Parker-Hannifin Corporation (the requested entity; exact legal-name match) | | Listing status | Public company — confirmed (matches input type) | | Legal name | Parker-Hannifin Corporation [Filing: FY2026 10-K cover] | | Former names | Parker Appliance Company (founding name); renamed Parker-Hannifin Corporation following the 1957 acquisition of Hannifin Corporation | | Founded | 1917, Cleveland, Ohio (by Arthur L. Parker) | | Incorporation | Ohio, 1938 [Filing: FY2026 10-K, Item 1] | | IRS Employer ID | 34-0451060 [Filing] | | Headquarters | 6035 Parkland Boulevard, Cleveland, Ohio 44124-4141, USA; tel. +1 216 896 3000 [Filing] | | Exchange / ticker | New York Stock Exchange: PH (common shares, $0.50 par) [Filing] | | ISIN | US7010941042 [Secondary] | | CUSIP | 701094104 (derived from ISIN) | | SEC Commission file no. | 1-4982 | | Filer status | Large Accelerated Filer; Well-Known Seasoned Issuer [Filing] | | Fiscal year end | 30 June | | Shares outstanding | 126,047,469 at 31 July 2026; 126,112,415 at 4 September 2026 (proxy record date) [Filing] | | Shareholders of record | 2,847 at 31 July 2026 [Filing] | | Employees ("team members") | ~59,850 at 30 June 2026, of which ~30,830 employed by foreign subsidiaries [Filing: FY2026 10-K] | | Auditor | Deloitte & Touche LLP (auditor since FY2008) [Filing: 2026 proxy] | | Non-affiliate market value | $110.76 billion at 31 December 2025 [Filing: 10-K cover] | | Market capitalization (latest verifiable) | ~$121.4 billion [Computed: $962.59 closing price on 5 Sept 2026 × 126.1M shares; Secondary price source]. | | Website | www.parker.com; investor site investors.parker.com | | Corporate rank | Fortune 250 (company self-description) | | Credit ratings (30 June 2026) | Moody's A3; S&P BBB+ (outlook raised to Positive in 2026 [Secondary]); Fitch A- [Filing: FY2026 10-K] | | Metric | FY2023 | FY2024 | FY2025 | FY2026 | |---|---|---|---|---| | Employees (approx., headcount) | 62730 | 61120 | 57950 | 59850 | Source: FY2026 from 10-K [Filing]; FY2023–FY2025 from prior 10-Ks as compiled by an aggregator [Secondary]. The FY2025 decline reflects the FY2025 divestitures of the composites and fuel containment (CFC) business and a non-core filtration business; the FY2026 increase reflects the Curtis Instruments acquisition (September 2025). The ~7,500 Filtration Group employees joined after fiscal year-end (13 August 2026) and are not in the FY2026 count. Parker-Hannifin is the world's largest pure-play motion-and-control technology company, combining eight interconnected core technologies — hydraulics, pneumatics, electromechanical, filtration, fluid and gas handling, process control, engineered materials and climate control — across two reportable segments: Diversified Industrial (67% of FY2026 sales) and Aerospace Systems (33%). The company sells hundreds of thousands of part numbers, none above 1% of sales, through OEM channels and a global distributor network serving several hundred thousand customer locations. Its decentralized operating model is run through "The Win Strategy™ 3.0", a business system credited with lifting adjusted segment operating margin from 22.3% (FY2022) to a record 27.3% (FY2026). Portfolio transformation — CLARCOR (2017), LORD and Exotic Metals (2019), Meggitt (2022), Curtis (2025), Filtration Group (2026) and the pending CIRCOR Aerospace deal — has shifted the mix toward aerospace, aftermarket and longer-cycle, higher-margin revenue. Management targets 30% adjusted segment margins by FY2031. --- ### What the company does — company description In its FY2026 Form 10-K, Parker describes itself as a global leader in motion and control technologies that uses a combination of interconnected technologies to design, manufacture and provide aftermarket support for highly engineered solutions, principally for aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration markets. The company emphasizes a decentralized operating structure intended to deepen customer relationships and team-member engagement, governed by The Win Strategy (goals: Engaged People, Customer Experience, Profitable Growth, Financial Performance) and anchored by the purpose statement "Enabling Engineering Breakthroughs that Lead to a Better Tomorrow". [Filing: FY2026 10-K, Item 1] ### Reportable segments and market verticals | Segment | FY2026 share of sales | Channels | Principal market verticals / platforms | |---|---|---|---| | Diversified Industrial | 67% ($14,438M) | OEMs and independent distributors (aftermarket replacement); field sales force | Aerospace & defense, in-plant & industrial equipment, transportation, off-highway, energy, HVAC & refrigeration | | Aerospace Systems | 33% ($7,061M) | Direct to OEMs and end users via regional sales organizations | Commercial transport, regional transport, defense fixed wing, helicopters, business jets, energy (industrial gas turbines) | [Filing: FY2026 10-K] ### Business and revenue model **Product vs. service vs. subscription vs. licensing mix.** Parker's revenue is overwhelmingly product revenue, recognized mostly at a point in time on shipment; a portion (largely aerospace development and long-production contracts) is recognized over time using cost-to-cost, efforts-expended or units-of-delivery methods [Filing: FY2026 10-K, Critical Accounting Policies]. The company does not disclose a numeric product/service/subscription/licensing split — not publicly disclosed. Repair, overhaul and spares in Aerospace Systems function as a service-like aftermarket annuity, and distributor-channel replacement parts in Diversified Industrial play the same role, but the aggregate aftermarket percentage for Parker as a whole is not disclosed in the filings reviewed. Disclosed indicators of aftermarket intensity include: Filtration Group derives ~85% of its sales from aftermarket replacement, and the deal lifts Parker Filtration's aftermarket share by ~500 bps [Filing: FGC press release, 11 Nov 2025]; Aerospace FY2026 Q3 aftermarket sales grew 14% with commercial OEM up 22% [Filing: Q3 FY2026 release]. **Value-chain position.** Parker is a Tier-1/Tier-2 component and subsystem supplier. In aerospace, it holds sole-source positions on airframe and engine programs (flight control, fuel, hydraulic, braking, thermal, inerting and fire-protection systems) from which it earns decades of follow-on spares and repair revenue. In industrial markets, it supplies engineered components (fittings, hose, valves, pumps, seals, filters, actuators, controls) into OEM equipment and services the installed base through distributors. **Customer types.** OEMs (aircraft and engine makers, machinery, truck, agricultural, construction, semiconductor-equipment, HVAC/R and energy-equipment builders), airlines and MRO providers, defense agencies and primes (including the U.S. government, which brings ITAR, EAR and CMMC obligations), and independent distributors. No single product exceeds 1% of sales [Filing]. **Pricing.** Management describes value-based pricing ("priced by the value they deliver") as a strategic objective [Filing: FY2026 10-K MD&A]. List-price or contract-pricing models are not publicly disclosed. ### Independent characterization Parker is best understood as a compounder of engineered-component franchises that uses a common operating system (Win Strategy, lean, Simple-by-Design, high-performance teams, "local-for-local" supply) to raise margins of acquired businesses. Since FY2022, three structural shifts are visible in the numbers: (1) aerospace mix has risen from 15.9% of sales (FY2022) to 32.8% (FY2026), with Aerospace now the highest-margin segment (26.0% reported, 29.9% adjusted); (2) margin step-change — total adjusted segment operating margin up 500 bps in four years; and (3) cash generation — FCF margin up from 13.9% to 18.2%. The FY2027 portfolio (with Filtration Group, Curtis and, if closed, CIRCOR Aerospace) will be more aftermarket-weighted and less exposed to the short-cycle North American industrial base that drove three years of flat-to-negative organic growth in FY2024–FY2025.

ServiceNow is the dominant workflow-orchestration layer of the modern enterprise, and it is now attempting the most consequential repositioning in its history: from "the digital workflow company" to, in management's own 2026 language, "the AI control tower for business reinvention." Its structural advantage is architectural rather than functional. A single data model, a configuration management database that most large enterprises already trust as their system of record for technology estate, and two decades of accumulated process knowledge give ServiceNow a privileged position as the execution layer beneath generative models that can reason but cannot act. That advantage is being pressed hard through capital deployment — $10.2 billion of acquisitions announced or closed between March 2025 and April 2026, principally Moveworks, Veza and Armis — which converts a debt-free, cash-rich balance sheet into a levered one and moves the company into direct competition with the security platform vendors. Execution risk has risen materially; so has the addressable opportunity. ServiceNow, Inc. is a Delaware-incorporated enterprise software company headquartered in Santa Clara, California, that sells a single multi-tenant cloud platform — now branded the ServiceNow AI Platform — on which customers automate, orchestrate and govern cross-functional business workflows. Founded in 2004 by Fred Luddy as Glidesoft, Inc., renamed Service-now.com in 2006 and ServiceNow in 2011, the company listed on the New York Stock Exchange in June 2012 and has compounded revenue at roughly 22.5% annually over the last four fiscal years (derived from Forms 10-K FY2021–FY2025). --- ### The company's own description ServiceNow describes itself in its FY2025 Form 10-K in terms that have shifted decisively toward artificial intelligence. The company states that it delivers solutions helping public and private organisations govern, secure and manage artificial intelligence while digitalising and streamlining workflows to drive collaboration, productivity and better experiences across the enterprise. It offers a suite of products, including AI-powered applications, and services designed to automate workflows, integrate systems and empower employees regardless of existing systems, cloud environments or collaboration tools. At the core sits the ServiceNow AI Platform — a cloud-based platform facilitating delivery of workflows and driving digital transformation across all departments and personas. The 10-K articulates a specific and defensible strategic thesis about where value accrues in the AI stack. Management's argument is that AI excels at analysing data and generating information, but converting that information into business outcomes requires infrastructure capable of orchestrating action across systems, enforcing governance policies and managing complex workflows. Models can identify patterns, recommend and surface insights, but cannot independently execute transactions, route approvals, update systems of record or enforce compliance with business rules. ServiceNow positions its platform as the infrastructure connecting AI-generated insight to the operational systems where work actually happens — the capability to direct, control and manage what happens after information is generated. In the company's framing, this represents a substantial share of the value enterprises seek when adopting AI. By the Q2 FY2026 release the corporate boilerplate had been rewritten again: ServiceNow is "the AI control tower for business reinvention," a platform that integrates with any cloud, any model and any data source, unifying legacy systems, departmental tools, cloud applications and AI agents into a single pane of glass, with more than 100 billion workflows running annually. ### Independent characterisation Stripped of marketing language, ServiceNow is a horizontal workflow platform-as-a-service business with three distinguishing economic characteristics. First, it is a land-and-expand seat-and-consumption hybrid. The company began in IT service management, a category with an unusually clear buyer (the CIO), an unusually measurable ROI (ticket deflection, mean time to resolution) and an unusually sticky artefact (the CMDB, the configuration management database). Having established that beachhead it has repeatedly extended the same platform into adjacent functional domains — IT operations, security operations, risk, HR, customer service, legal, procurement, facilities, and most recently sales and order management. The economics of that expansion are extraordinarily favourable because the incremental product rides on infrastructure, sales relationships and implementation partners already paid for. Management disclosed at its May 2026 Financial Analyst Day that 91% of net new annual contract value in 2025 came from deals containing five or more products, which is the clearest single quantification of the cross-sell engine. Second, the revenue model is overwhelmingly subscription. Subscription revenue was $12,883 million of $13,278 million total in FY2025 — 97.0% of the total (Form 10-K FY2025). Professional services and other revenue was $395 million, or 3.0%, and is deliberately run at or below break-even; the FY2025 GAAP professional services gross loss was $19 million, a negative 4.5% margin (Q4 FY2025 earnings release). ServiceNow does not want to be a services business; it wants systems integrators to be the services business, which is why Accenture, Deloitte, EY, KPMG, Infosys, Cognizant and NTT DATA are named partners in the FY2025 10-K. Third, and newly material, pricing is migrating away from seats. Management stated at the May 2026 analyst day that half of net new ACV had already shifted to non-seat-based pricing models, and that new AI-native bundles were expected to drive average price lift of roughly 20% or more. The FY2025 10-K confirms that certain AI and data solutions now include a consumption-based component that applies when customer usage exceeds the fixed number of service credits under the subscription agreement. This is the company's structural answer to the "seat compression" bear case: if AI reduces the number of human agents an enterprise employs, ServiceNow wants to be paid for the work performed rather than the people performing it. ### Customers, value-chain position and end markets ServiceNow sells almost exclusively to large enterprises and government. As of 31 December 2025 the company had approximately 8,700 customers (Form 10-K FY2025). Concentration among very large accounts is high and rising: 603 customers with more than $5 million in annual contract value at 31 December 2025, against 502 at 31 December 2024 and 420 at 31 December 2023 (Form 10-K FY2025). By Q2 FY2026 that count had reached 658, approximately 23% year-over-year growth (Q2 FY2026 earnings release). Go-to-market is a global direct sales organisation supplemented by managed service providers and resale partners; the FY2025 10-K explicitly notes that an increasing portion of revenue is generated through the partner network, and that a substantial majority of United States government sales are made indirectly through distributors, resellers or service providers. End markets served, per the FY2025 10-K's industry solutions disclosure, are financial services, healthcare and life sciences, manufacturing, public sector, retail, technology and telecommunications. Public sector is a disproportionately important and disproportionately risky vertical: it drives contract-duration mix effects that management repeatedly calls out in cRPO guidance, and it is the source of the company's principal open legal exposure. In value-chain terms ServiceNow occupies the orchestration and governance layer: above the infrastructure providers (AWS, Microsoft Azure, Google Cloud, on which an increasing share of ServiceNow instances are hosted), above the frontier model providers (Anthropic, OpenAI, NVIDIA-enabled inference), and above or alongside the systems of record (SAP, Oracle, Workday, Salesforce) whose data it federates without replicating. That position is simultaneously its greatest asset and its greatest dependency, because the same hyperscalers and model providers are its most credible long-run competitors.

Avery Dennison is the world's largest producer of pressure-sensitive label materials and the leading supplier of ultra-high-frequency RFID inlays. It has repositioned itself from a label-stock manufacturer into what it calls a materials science and digital identification solutions company. Two segments carry the franchise. Materials Group (about 69% of FY2025 sales) coats, laminates and sells label, graphics, reflective and tape materials to a fragmented base of converters. Solutions Group (about 31%) sells apparel branding, RFID-enabled intelligent labels, external embellishments and Vestcom shelf-edge solutions to brands and retailers. Roughly 45% of revenue now comes from higher-growth, higher-margin "high-value categories". The investment case rests on scale and cost leadership in a consumer-staples-anchored base business, a long structural runway for item-level digital identity in apparel, food and logistics, a disciplined productivity culture and consistent capital return. The risks are cyclical apparel exposure, raw-material and tariff volatility and uneven RFID programme timing. --- ### The company's own description In its FY2025 Form 10-K, Avery Dennison describes itself as a global leader in materials science and digital identification solutions. Its stated purpose is to provide branding and information solutions that improve labour and supply-chain efficiency, reduce waste and loss, advance sustainability, circularity and transparency, and connect brands with consumers. It designs and develops labelling and functional materials, RFID inlays and tags, software that links physical items to digital records, and products that enhance branded packaging and carry or display information. End markets named in the filing are home and personal care, apparel, general retail, e-commerce, logistics, food and grocery, pharmaceuticals and automotive. The filing lists the company's competitive advantages as exposure to diverse and growing markets, scale of operations, innovation capability, a productivity culture and brand strength. International operations generated about 69% of FY2025 net sales and emerging markets about 40%. At year-end 2025 the company operated more than 200 manufacturing and distribution facilities in more than 50 countries. ### Independent characterisation Analytically, Avery Dennison is three businesses under two reporting segments: 1. **A global roll-goods coating franchise (label and graphic materials).** This is a high-volume, capital-intensive, scale-driven business. The company buys paper, films, resins and adhesives, then coats and laminates them into pressure-sensitive constructions sold in roll or sheet form, mainly to label converters who print and die-cut for consumer-goods brand owners. Demand is anchored in consumer staples (food, beverage, home and personal care, pharmaceutical) and in variable-information labelling (logistics, e-commerce, retail weigh-scale). Pricing largely passes raw-material inflation and deflation through with a lag, which is why reported sales can fall while volume grows, as in FY2023–FY2025. 2. **A specialty materials portfolio (graphics, reflectives, performance tapes, medical, and since October 2025 flooring adhesives).** This is lower-volume and more application-engineered, serving automotive, building and construction, electronics, signage and fleet, traffic safety and healthcare. 3. **An information and branding solutions business (Solutions Group).** It sells directly to apparel brands, retailers, grocers and logistics operators. It combines a legacy apparel trim business (tags, woven and printed labels, heat transfers, packaging) with three growth platforms: Intelligent Labels (UHF RFID inlays, tags and associated software), Embelex external embellishments (team-sport and performance-brand decoration), and Vestcom (data-driven shelf-edge pricing, productivity and retail media for US grocery, drug and mass retailers). **Revenue model.** The company is overwhelmingly a product seller. Revenue is recognised mainly at a point in time on shipment of manufactured goods. There is no material subscription or licensing revenue line. Software (the atma.io connected-product cloud, Optica solutions, Vestcom data services) is largely bundled into, or an enabler of, consumable label and tag sales, and the company does not disclose a recurring-software revenue figure. One stated near-term priority in the 2026 Proxy Statement is to increase digital and artificial-intelligence outcomes, including accelerating digital revenue. **Value chain position.** In Materials the company is a midstream converter of commodity and specialty inputs into engineered laminates. It sits between large chemical, paper and film suppliers and thousands of label converters and sign shops. In Solutions it is a direct, specification-driven supplier to brands and retailers, with production co-located near apparel sourcing hubs in South and Southeast Asia, China and Central America. **Customer concentration.** No single customer represented 10% or more of FY2025 net sales (FY2025 Form 10-K). The filing notes ongoing consolidation and vertical integration among converter customers. In January 2026 a large Materials Group customer (unnamed in the filing) filed a prepackaged Chapter 11, and the company expected to collect its pre-petition receivables. **High-value categories.** Management divides the portfolio into "high-value categories" and "base" businesses. High-value categories are specialty and durable labels, graphics and reflectives, performance materials including tapes and specialty adhesives, Intelligent Labels, Vestcom and Embelex. They reached about 45% of revenue in FY2025 and carry above-average margins (FY2025 earnings release; 2026 Proxy Statement).

### Identity and listing | Field | Detail | |---|---| | Entity profiled | Eastman Chemical Company (exact legal-name match; active; publicly listed) | | Listing status vs. input list | Confirmed public company — matches the type supplied | | Former names / predecessors | Tennessee Eastman Company / Corporation (Kodak's chemical subsidiary, founded 1920); Eastman Chemical Products (marketing arm); operated as Eastman Kodak's chemicals division until spin-off | | Founding year | 1920 (Kingsport, Tennessee, by George Eastman) | | Incorporation | Delaware, 1993 (2026 Proxy, "Eastman at a Glance") | | Spin-off from Eastman Kodak | Effective 31 Dec 1993; NYSE trading from early January 1994 | | Headquarters | 200 South Wilcox Drive, Kingsport, Tennessee 37660, USA | | Exchange / ticker | New York Stock Exchange: EMN | | ISIN / CUSIP | US2774321002 / 277432100 (standard identifiers; not re-checked against filing cover page) | | Fiscal year end | 31 December | | Auditor | PricewaterhouseCoopers LLP (ratified for FY2026 at 7 May 2026 AGM; lead partner rotated in 2026) | | Website | www.eastman.com | | Market capitalization | USD 7.39 billion (5 Oct 2026, share price USD 64.62; 114.33 million shares) | | Enterprise value | USD 12.16 billion (S&P Global via StockAnalysis, 5 Oct 2026) | | Credit ratings | Moody's Baa2 (outlook negative, changed ~Aug 2026); S&P BBB (outlook negative since Aug 2025, affirmed Nov 2025); Fitch: BBB historically (current outlook n/v) | | CEO & Board Chair | Mark J. Costa (CEO since January 2014) | | Customers served | More than 100 countries | | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Employees (approx., headcount) | 14000 | 14000 | 13000 | Sources: FY2024 headcount from company boilerplate in August 2025 releases ("approximately 14,000"); FY2025/2026 from FY2025 results release and 2026 Proxy ("approximately 13,000"). The roughly 7% reduction between 2024 and 2025 aligns with corporate severance charges of USD 34 million booked in FY2025 (FY2025 financial tables, Table 3A note 7). Eastman is a ~USD 8.8 billion, Kingsport-headquartered specialty materials producer whose competitive identity rests on deeply integrated, largely U.S.-based asset complexes in Tennessee and Texas that convert coal-derived syngas, cellulose, propane and—increasingly—waste plastic into higher-value polymers, films, additives and fibers. Roughly two-thirds of revenue comes from two specialty segments (Advanced Materials and Additives & Functional Products) anchored by franchise brands such as Saflex interlayers, LLumar window films, Tritan copolyester, Therminol heat-transfer fluids and Naia textiles. The remaining third—Chemical Intermediates and Fibers—supplies scale, integration economics and cash but carries commodity cyclicality and structural decline risk (acetate tow). Management's differentiator is an "innovation-driven growth model" layered with a circular-economy platform (Kingsport methanolysis molecular recycling). The investment debate centres on whether innovation and circularity can outrun cyclical demand, an elevated 3x+ leverage profile, and a decade of flat-to-declining revenue. --- ### Company's own description (paraphrased from FY2025 releases and 2026 Proxy) Eastman describes itself as a global specialty materials company that produces a broad range of products found in everyday items, with a stated purpose of enhancing the quality of life in a material way. It attributes its growth to an innovation-driven model built on world-class technology platforms, deep customer engagement and differentiated application development, which it uses to grow leading positions in attractive end markets—explicitly naming transportation, building and construction, and consumables. The 2026 Proxy adds that its strategy is founded on innovating sustainable solutions and maintaining its social license to operate, framed around a "triple challenge" of carbon neutrality, circularity and caring for society. ### Independent characterization Eastman is best understood as a hybrid specialty/intermediates producer whose specialty franchises sit on top of integrated commodity-like streams. Four integrated technology streams underpin the portfolio: 1. **Acetyl/cellulosics stream (Kingsport):** coal gasification produces syngas → methanol → acetic acid/acetic anhydride; combined with wood pulp to make cellulose esters (cellulose acetate flake, CAB, CAP). Outputs feed acetate tow and textile yarn (Fibers), cellulose-ester coatings additives (AFP), and cellulose-based plastics (AM). 2. **Polyester/copolyester stream (Kingsport):** proprietary monomers (e.g., CHDM, TMCD) enable Tritan and Eastar copolyesters; the methanolysis molecular-recycling unit depolymerizes polyester waste back into monomers that substitute for virgin feedstock. 3. **Olefins/oxo stream (Longview, Texas — second-largest site):** propane/ethane cracking → propylene/ethylene → oxo alcohols, plasticizers, glycol ethers and solvents (Chemical Intermediates), plus feedstock for specialty additives. 4. **Alkylamines and specialty fluids (Taminco/Solutia heritage):** methylamines, ethylamines and higher amines for agriculture, water treatment, personal care and pharma; Therminol heat-transfer fluids and Skydrol aviation hydraulic fluids. ### Revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Product sales (B2B) | ~99%+ | Essentially all revenue is from manufactured-product sales under spot, contract and cost-pass-through arrangements | | Technology licensing | Not separately disclosed (immaterial) | Oxo process technology licensing; APAC licensing programs were discontinued in 4Q2025 (USD 13 million adjustment in CI segment) | | Services / subscription | None material | Technical service is bundled with product sales | Pricing mechanisms (FY2025 releases): AFP uses cost-pass-through contracts for a meaningful share of volume (price +3% in FY2025 explicitly attributed to them); Fibers acetate tow is sold under annual contracts with minimum commitments (2Q2026 call: tow volumes rise in 2H as customers meet annual minimums); CI is spread-driven against propane/ethylene and Asian competition; AM is value-priced (management "defended price" in 4Q2025 despite volume declines). ### Value-chain position Eastman sits in the mid-stream to downstream of the chemical value chain: it is backward-integrated into basic feedstocks (syngas, olefins) but sells primarily to converters and OEM tier suppliers—windshield laminators, film converters/installers, plastic molders, coatings formulators, agrochemical formulators, cigarette-filter makers and textile mills—rather than to consumers. Brand recognition at consumer level exists for a few franchises (LLumar films, Tritan in drinkware, Naia in apparel), which supports co-branding and pricing. ### Customer types and end markets The 2026 Proxy lists FY2025 revenue by end-use market across: Transportation; Building and Construction; Consumables; Durables and Electronics; Personal Care and Wellness; Filter Media; Medical and Pharma; Industrial Chemicals; Food, Feed and Agriculture; Water Treatment and Energy; and Other Markets. The proxy states 56% of revenue arises outside North America (FY2025). Customer concentration: no single customer is disclosed as ≥10% of sales in sources reviewed (n/v).

Codexis is a Redwood City-based enzyme engineering company in the middle of a deliberate transition. It is moving from a diversified "protein engineering" platform company, whose revenue was historically dominated by custom biocatalysts for small-molecule drug manufacturing, toward a focused provider of enzymatic manufacturing solutions for oligonucleotide therapeutics, chiefly siRNA/RNAi. Its proprietary CodeEvolver® directed-evolution platform underpins two businesses. The first is a cash-generating but lumpy pharma biocatalysis franchise, anchored by long-standing relationships with Merck & Co. and other large pharmaceutical companies, which supports about 14 commercial products. The second is the pre-commercial ECO Synthesis® Manufacturing Platform, which aims to replace solid-phase phosphoramidite chemistry with enzymatic routes, together with a commercially launched dsRNA ligase. The company is a sub-$200 million market capitalization micro-cap and remains loss-making. It has about $80 million of pro forma liquidity, a $40 million term loan, and guidance for FY2026 revenue of $72–76 million. --- ### Company's own description (FY2025 10-K / standard press-release boilerplate, paraphrased) Codexis describes itself as a leading provider of enzymatic solutions for efficient, scalable therapeutics manufacturing. It discovers, develops and improves high-performance enzymes using its proprietary CodeEvolver® technology. According to the company, its enzymes address real-world problems in small-molecule pharmaceutical manufacturing and nucleic acid synthesis. Codexis is developing the ECO Synthesis® Manufacturing Platform to enable scaled manufacture of RNAi therapeutics through an enzymatic route. It says its enzymes can raise yields, cut energy use and waste, improve manufacturing efficiency, and increase sensitivity in genomic and diagnostic applications (Codexis Q4 FY2025 and Q2 FY2026 press releases). The FY2025 10-K states that headquarters is both the administrative centre and the centre of research, development and business operations, with limited internal manufacturing capacity. In-house manufacturing produces Codex® biocatalyst panels and kits, plus enzymes for customers' pilot-scale and clinical production. The ECO Synthesis Innovation Lab sits inside headquarters and is designed to supply non-GMP material in quantities that support customers' preclinical development. The company expects to partner with CDMOs for bulk GMP-grade siRNA production for clinical supply and beyond. ### Independent characterization Codexis is best understood as a technology-licensing and specialty-enzyme supplier whose economics depend on a small number of very large pharmaceutical relationships. In FY2025 a single customer accounted for about 51% of total revenue (FY2025 10-K, "Customers"). Given the $37.8 million Merck agreement recognised mainly in Q4 FY2025, that customer is almost certainly Merck. The business model has three monetization layers. The first layer is product revenue: sales of engineered enzymes (biocatalysts), pharmaceutical intermediates, Codex® biocatalyst screening panels and kits, and, increasingly, ligase and ECO enzyme supply. Product revenue is driven by customers' commercial manufacturing schedules and is therefore volatile quarter to quarter. Product gross margin has improved structurally, from 56% in FY2024 to 64% in FY2025 and 71–73% in Q1–Q2 FY2026. Management attributes this to a shift toward higher-margin products and the run-off of lower-margin legacy products. The second layer is research and development revenue: CodeEvolver platform licence fees, technology-transfer payments, milestone payments, feasibility and evaluation fees, and ECO Synthesis manufacturing services (for example, the low-seven-figure contract to supply 50 g of siRNA). In FY2025 R&D revenue exceeded product revenue for the first time in the period analysed ($44.4 million vs. $26.0 million). The main reason was the Merck technology transfer. The third layer is royalty and contingent consideration from out-licensed or divested assets. These include the Nestlé Health Science CDX-7108 sale (up to $45 million in milestones plus a single-digit royalty), the Aldevron HiCap RNA polymerase licence (milestones and royalties), and the Roche dsDNA ligase licence (upfront and technical milestones). These are largely back-ended and uncertain. **Value-chain position.** Codexis sits upstream of drug-substance manufacturing. It supplies process technology (enzymes and the know-how to use them) to innovator pharma companies, generic manufacturers and CDMOs, which then run the commercial processes. In the oligonucleotide chain it is trying to move one step downstream. Its planned ECO GMP Manufacturing Center would make siRNA material for preclinical and Phase 1 supply. This hybrid "tool supplier plus early-phase manufacturer" model is a new risk profile for the company. **Customer types:** large innovator pharma (Merck, plus historically Pfizer, GSK and Novartis); high-growth RNAi biotech innovators (unnamed counterparties in 2025–2026 agreements); CDMOs (Bachem, Nitto Denko Avecia, Axolabs); and life-science tools companies (Roche, Aldevron, seqWell). **End-markets served:** small-molecule API manufacturing (biocatalysis); oligonucleotide/RNAi therapeutic manufacturing; and, as a residual licensing stream, life-science tools and genomics reagents. ### Revenue model mix (FY2021–FY2025) | Revenue type (USD M) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Product revenue | 70.7 | 116.7 | 42.9 | 36.8 | 26.0 | | Research and development revenue | 34.1 | 21.9 | 27.2 | 22.6 | 44.4 | | Total revenue | 104.8 | 138.6 | 70.1 | 59.3 | 70.4 | | Product revenue share of total (%) | 67.5 | 84.2 | 61.2 | 62.0 | 37.0 | | PAXLOVID-related enzyme sales (CDX-616) | 34.5 | 75.4 | 8.1 | NA | NA | *Sources: Q4 FY2022 press release (FY2021–FY2022 PAXLOVID figures); FY2023 10-K (product revenue); Q4 FY2023 press release (ex-PAXLOVID revenue of $62.0 million implies about $8.1 million PAXLOVID-related revenue in FY2023, largely the release of deferred Pfizer fees); Q4 FY2025 8-K Exhibit 99.1 (FY2024–FY2025). Shares are computed.*

Lubrizol is one of the world's largest specialty chemical companies that is not publicly traded. It is best known as the global leader in lubricant and fuel additives, the chemistry that lets engine oils, transmission fluids, gear oils and industrial lubricants meet ever-tighter OEM and regulatory specifications. On top of that franchise sits a second, more diversified Advanced Materials business: thermoplastic polyurethanes (Estane, Pearlthane), CPVC resins and compounds for plumbing and fire sprinklers (TempRite, FlowGuard Gold, BlazeMaster, Corzan), performance coatings additives (Solsperse, Aptalon), and life-science ingredients for beauty, personal care, home care, pharmaceuticals and medical devices (Carbopol, Noveon, contract medical manufacturing). Since 2011 it has been a Berkshire Hathaway subsidiary generating roughly $6–7 billion of annual revenue. It competes in a concentrated additives oligopoly against Infineum, Chevron Oronite and Afton. Its strategic challenge is long-term decline in internal-combustion engine oil volumes, which it is offsetting with growth in materials, healthcare, India and Asia. --- ### Company's own description (latest annual filing) Berkshire's FY2025 Form 10-K (filed 2 March 2026) describes Lubrizol as a specialty chemical and performance materials company that makes products and supplies technologies for the global transportation, industrial and consumer markets. It reports two operating segments: **Lubrizol Additives:** engine lubricant additives, driveline lubricant additives and industrial specialties products. **Lubrizol Advanced Materials:** engineered materials (engineered polymers and performance coatings) and life sciences (beauty, personal care, health and home care solutions). The filing lists the applications as follows. Additives go into engine oils, transmission fluids, gear oils, specialty driveline lubricants, fuels, metalworking fluids and compressor lubricants. Advanced Materials products go into beauty, personal care, home care, over-the-counter pharmaceuticals, medical devices, performance coatings, sporting goods, plumbing and fire-sprinkler systems. The filing names Infineum International Ltd., Chevron Oronite Company and Afton Chemical Corporation as the principal Additives competitors. Lubrizol's raw materials are mainly petroleum- and petrochemical-derived feedstocks. Single-source materials are covered by long-term supply contracts. No single customer exceeded 10% of Lubrizol revenue in FY2025. ### Business model and revenue model | Revenue model element | Characterization | Evidence | |---|---|---| | Product sales (dominant) | Effectively all revenue is product sales of formulated additive packages, polymers, resins, compounds and ingredients. Sold by volume (metric tons) at negotiated prices, often with raw-material pass-through clauses | BRK 10-K narrative attributing revenue changes to "selling prices," "volumes" and "product mix" | | Services | Minor. Contract development and manufacturing for medical devices (Lubrizol Life Science Health, BMT, Avid 3D printing), engine/OEM testing and specification-approval support bundled into additive sales | Acquisition releases 2019–2020 | | Licensing | Not separately disclosed. Technology is monetized mainly through proprietary formulations, not royalties | — | | Subscription | None | — | **Value-chain position:** Lubrizol sits in the middle of the value chain. It buys base chemicals (olefins, polyisobutylene inputs, phosphorus/zinc compounds, sulfonates, PVC, isocyanates/polyols, acrylic monomers). It then makes intermediates and formulates them into proprietary multi-component "packages" or specialty polymers, which it sells to formulators: oil marketers who blend finished lubricants, pipe extruders, footwear and film converters, and consumer-goods brand owners. In additives, the critical moat is the OEM/industry specification approval process (API, ILSAC GF-7, ACEA, OEM-specific approvals). Each package must pass costly engine tests. Once a marketer qualifies a Lubrizol package in its oil brand, switching suppliers means re-testing, which creates high switching costs and annuity-like volumes. **Customer types:** Major global and regional oil companies (Berkshire describes some largest customers as also suppliers), independent lubricant blenders, OEMs (indirectly through specifications), pipe and fitting manufacturers (CPVC), consumer-goods companies (P&G/Unilever-type formulators; specific customers not disclosed), pharmaceutical and medical-device OEMs, and coatings and ink formulators. **End-markets served (company language):** transportation, industrial, consumer, beauty and personal care, health, home care, electronics, and building and construction. ### Independent characterization Lubrizol is economically two companies. 1. **A mature, cash-generative oligopoly franchise (Additives).** Historically about 70% of revenue (72% in FY2010, the last segment disclosure). Profitability depends on raw-material spreads (lagged pricing), volumes tied to the global vehicle parc, and the frequency of specification upgrades, which shift share to the technology leader. The 2011 Bloomberg analysis credited Lubrizol with about 35% of sales in an industry dominated by four companies. The structural headwind is electrification (BEVs need no engine oil), plus share pressure from Chinese additive producers. 2. **A portfolio of specialty materials and ingredients businesses (Advanced Materials).** Historically about 28–30% of revenue but faster-growing and more fragmented. The real growth vectors are CPVC (India infrastructure), TPU (paint protection film, footwear, medical) and life sciences (pharma excipients, medical devices). FY2025 shows the pressure on the model. Revenue fell 3.0% to $6.2 billion and pre-tax earnings fell 20.6%. Berkshire attributed this to lower prices and volumes, higher manufacturing costs, restructuring costs from exiting certain businesses, and litigation expenses (BRK 10-K FY2025). H1 2026 shows recovery: revenue +7.0% and pre-tax earnings +16.5% (BRK 10-Q Q2 2026).

Innospec is a mid-cap, debt-free specialty chemicals group with about USD 1.8bn of revenue (FY2025). It is built around three technically differentiated, service-intensive franchises: **Fuel Specialties:** (39% of FY2025 sales; about 63% of segment operating income before corporate costs). This is a world-class fuel-additives business. It is independent of the oil majors, earns a 36% gross margin, and is the world's only producer of tetraethyl lead (TEL) for aviation gasoline. **Performance Chemicals:** (38%). Mild, sulfate-free and 1,4-dioxane-free surfactants and emollients for personal and home care, plus agrochemical, mining and construction chemistries. Manufacturing is concentrated in North Carolina, Europe and Brazil. **Oilfield Services:** (22%). Drilling, completion, production and drag-reducing-agent (DRA) chemistry, mainly for the US and the Middle East. The investment case rests on Fuel Specialties' annuity-like cash generation and an under-levered balance sheet with about USD 250–290M of net cash. Optionality comes from margin repair in Performance Chemicals and Oilfield Services. The key debates are the durability of the 2025–26 recovery and the long-dated AvGas/TEL phase-out. --- ### Company's own description (10-K FY2025, Item 1, paraphrased) Innospec develops, manufactures, blends, markets and supplies specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Its three reportable segments are: **Performance Chemicals:** technology-based solutions for personal care, home care, agrochemical, construction, mining and other industrial markets. **Fuel Specialties:** fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. **Oilfield Services:** chemicals for drilling, completion, production and DRA, which make oil and gas exploration and production more cost-efficient and environmentally friendly. The stated strategy is: - develop new and improved products and technologies to strengthen market positions in all three segments; - assess strategic acquisitions and partnerships that extend the technology base, geographic coverage or product portfolio; - stay inside adjacent markets where Innospec already has expertise, which management argues lowers operating risk. ### Business and revenue model **Product-based model:** Revenue is almost entirely from sales of formulated and manufactured specialty chemicals, with technical service bundled in. There are no material subscription, licensing or royalty streams. **Contracts:** Long-term supply contracts, often with fixed or formula-based pricing, sit alongside spot and order-book sales. **Value chain position:** Innospec is a mid-stream formulator and manufacturer. It buys commodity and intermediate feedstocks and sells performance-critical, low-volume-share ingredients to brand owners, refiners, fuel marketers and E&P operators. Key feedstocks are oleochemicals and derivatives, cetane number improvers, ethylene, solvents, amines, alcohols, olefins and polyacrylamides. **Supply concentration:** One German operation receives ethylene by direct pipeline, which makes it effectively single-source. Products from that operation are about 4% of group sales (10-K FY2025). **Customers:** - large multinational personal and home care companies; - national and multinational oil companies, fuel marketers, retailers, terminals and marine lines; - coatings and plastics producers; - multinational and independent E&P and oilfield service companies. **Customer concentration:** No single customer exceeded 10% of net sales in FY2024 or FY2025. In FY2023, one Oilfield Services customer accounted for USD 265.2M, or 13.6% of group sales (10-K FY2025). This was the Latin American / Mexican production-chemicals relationship whose collapse explains most of the FY2024–FY2025 Oilfield Services decline. **End-markets:** - Personal care: shampoos, body wash, syndet bars, cosmetics. - Home care: detergents and cleaners. - Agrochemicals: adjuvants and formulants. - Mining: flotation and processing aids. - Construction. - Diesel, gasoline, jet, marine and heating fuels; renewable fuels. - Piston aviation (AvGas TEL). - Non-fuel industrial applications of fuel technologies. - Oil and gas drilling, completions (fracturing), production and pipeline transport (DRA). ### Independent characterization Innospec is effectively three businesses with very different economics. **Fuel Specialties:** is a high-return, cash-generative oligopoly niche. Gross margin was 36.0% and operating margin 20.6% in FY2025. It is now consistently within management's 32–35% gross-margin and 19–21% operating-margin targets. **Performance Chemicals:** is a scale-sensitive surfactants and emollients franchise. Its returns depend on plant utilization in North Carolina and on passing through oleochemical (palm/coconut-derived) input costs. Gross margin fell from 23.4% (FY2022) to 17.9% (FY2025). **Oilfield Services:** is a cyclical, service-heavy, customer-concentrated business. Revenue more than doubled from FY2021 to FY2023 on Latin American production chemicals, then fell 43% from FY2023 to FY2025 when that business stopped. Group capital intensity is low: - capex was USD 50.3M in FY2025, about 2.8% of sales; - capitalized software spending was a further USD 25.2M in FY2025, reflecting a multi-year ERP rollout. The balance sheet has carried net cash every year since FY2021, which gives Innospec unusual M&A capacity for its size.

Afton Chemical is one of the four global majors in petroleum additives, alongside Lubrizol, Infineum and Chevron Oronite. It designs, manufactures and blends formulated additive packages for engine oils, driveline fluids, industrial lubricants and fuels, and sells them to oil majors, national oil companies and independent blenders rather than to end users or OEMs. It is the smallest of the four majors but the only one whose economics are visible through a pure-play listed parent. Its edge rests on formulation know-how, OEM approval breadth, a customer-intimate commercial model and a manufacturing network spanning the United States, Belgium, Singapore, Mexico and Brazil. The segment generated about USD 2.5 billion of sales and USD 520 million of operating profit in FY2025, a margin above 20%, and funds its parent's diversification into aerospace and defence specialty materials. The structural question is the pace of lubricant demand erosion from electrification against Afton's lead in e-driveline fluids. --- **What the company does.** Afton develops and manufactures chemical components, then combines them into formulated additive packages for specified applications. The FY2025 10-K frames the petroleum additives market as two applications. Lubricant additives are formulated chemistries blended with base fluids to improve efficiency, durability and functionality of mineral, synthetic and biodegradable oils. Fuel additives are either components that help refiners meet specifications or formulated packages that improve gasoline, diesel and biofuel performance. **Company's own description.** NewMarket's FY2025 10-K calls Afton "one of the largest lubricant and fuel additives companies in the world" and attributes its success to delivering customer value through an open, flexible and collaborative working style, backed by technical capability, formulation expertise, differentiated products and global supply. **Independent characterisation.** Afton is a formulation-led specialty chemical business with oligopoly characteristics. Additive packages are a small share of finished-lubricant cost but determine whether an oil passes industry and OEM tests, so switching costs are high and qualification programmes are expensive. That supports pricing discipline and margins well above commodity chemicals. The business is nonetheless volume-exposed to miles driven, drain intervals and industrial activity, and margin-exposed to the lag between raw material movements and selling prices. **Revenue model.** Revenue is almost entirely product sales (additive packages and components). Services such as testing and technical support are embedded in the customer relationship rather than billed as a disclosed revenue line. No subscription or licensing revenue is disclosed.

Olin is a vertically integrated North American chlor-alkali producer with three businesses: commodity chlorine chemistry, epoxy, and ammunition. It runs among the world's largest electrochemical-unit (ECU) capacity bases, chiefly at Freeport (Texas), Plaquemine (Louisiana), and McIntosh (Alabama). From that base it sells caustic soda, chlorine derivatives, and ethylene dichloride (EDC) and vinyl chloride monomer (VCM). It also feeds chlorine internally into one of the world's most integrated epoxy chains. Separately, its Winchester segment is one of the leading U.S. ammunition makers. Winchester operates the government-owned Lake City Army Ammunition Plant, which supplies most of the U.S. Army's small-calibre ammunition. After a record 2021–2022 super-cycle, earnings fell sharply. FY2025 adjusted EBITDA was $651.8M against $873.9M in FY2024. Causes included weak global chlor-vinyl and epoxy demand, subsidised Asian epoxy imports, and commercial ammunition destocking. Leverage rose to about 5x net debt/EBITDA by mid-2026. Management under CEO Ken Lane, in post since March 2024, has responded with a "value-first" commercial posture, the "Beyond250" structural cost programme, and now a transformational merger with Huntsman. The merger is intended to pair Olin's upstream chlorine molecules with Huntsman's downstream polyurethane and advanced-materials formulations. --- ### Company's own description (paraphrased from the FY2025 10-K, Item 1) | Segment | Share of FY2025 sales | Products described in the 10-K | |---|---|---| | Chlor Alkali Products and Vinyls (CAPV) | 54% | Chlorine, caustic soda, EDC, VCM, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach, and potassium hydroxide | | Epoxy | 20% | Aromatics (acetone, phenol), allyl chloride, epichlorohydrin, liquid and solid epoxy resins, and formulated solutions (converted resins, additives) | | Winchester | 26% | Sporting ammunition, reloading components, small-calibre military ammunition and components, industrial cartridges, and clay targets, plus contracted U.S. military project revenue | Olin describes itself as a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. ammunition manufacturer. All three segments are capital-intensive manufacturing businesses. ### Business model and revenue model Olin's revenue is almost entirely product revenue. There is no meaningful subscription or licensing income. The main exception is contracted U.S. military project revenue at Winchester, which is recognised over time on construction and modernisation work at Lake City. **CAPV economics:** Chlorine and caustic soda are co-produced in fixed ratio as one "ECU" (about 1 tonne chlorine to about 1.1 tonnes caustic soda). Profitability depends on the combined ECU value, which in turn depends on: - caustic soda pricing (alumina, pulp and paper, water treatment, and chemicals demand), and - the value of chlorine outlets (EDC/VCM for PVC, chlorinated organics, epoxy, bleach, and hydrochloric acid). - **Olin's "value-first" strategy**, introduced under former CEO Scott Sutton in 2020–2021 and continued by Ken Lane, keeps ECU operating rates matched to demand rather than chasing volume. The aim is to protect price. **Epoxy economics:** Margins depend on the spread between epoxy resin prices and benzene, propylene, and chlorine input costs. The segment has been structurally challenged by Asian (notably Chinese) export pricing since 2023. **Winchester economics:** The business is a mix of: - cyclical, sentiment-driven commercial ammunition (sold to retailers, mass merchants, and distributors), and - contracted, stable military ammunition and Lake City project revenue. ### Value-chain position Olin sits upstream. It converts salt, electricity, ethylene, benzene, and propylene into commodity and intermediate chemicals. Its formulated epoxy solutions and Winchester branded ammunition are the only meaningful downstream activities. The Huntsman merger is explicitly designed to move the combined company downstream. Olin's chlorine and caustic would feed Huntsman's MDI/polyurethane, formulations, and advanced-materials chains (Olin/Huntsman merger release, 16 June 2026). ### Customer types and end-markets | Segment | Customer types | Principal end-markets | |---|---|---| | CAPV | Industrial chemical producers, PVC makers (VCM/EDC buyers such as Shintech), pulp and paper, alumina refiners, water-treatment utilities, bleach distributors | Construction (PVC), water treatment, pulp and paper, alumina, chemicals, pharmaceuticals, food processing, energy | | Epoxy | Coatings formulators, composites makers, electronics laminators, wind-blade makers, civil engineering contractors | Protective and marine coatings, wind energy, electrical laminates, automotive, construction, adhesives | | Winchester | Mass merchants, sporting goods retailers, distributors, U.S. Army and DoD, international militaries, law enforcement, industrial users | Hunting, recreational shooting, personal defence, military, law enforcement, construction (powder-actuated tool loads) | ### Independent characterisation Olin is best understood as a levered, high-fixed-cost commodity chemicals platform with an embedded defence and consumer franchise. **Cost advantage:** Its key competitive advantage is position on the North American cost curve: advantaged ethane-based ethylene, low-cost power contracts, and scale. This advantage remained intact through 2025. **Product mix:** Its product mix has been the problem. The chain is long on EDC, an export commodity, and long on epoxy, a market Asian capacity has commoditised. **Winchester's role:** Winchester was the stabiliser in 2023–2024, earning about $238–256M of segment income. It became a drag in 2025 (segment income $67.7M) as commercial demand normalised and copper and propellant costs spiked. **Investment thesis:** The thesis now hinges on three things: the cycle trough in chlor-vinyls and epoxy, Beyond250 self-help, and Huntsman merger execution.

### Identity and listing | Item | Detail | |---|---| | Entity profiled | Illinois Tool Works Inc. (exact legal-name match; active; publicly listed). The input classification "Public company" is confirmed | | Former names | None of significance disclosed. The company has operated as Illinois Tool Works since founding. Commonly abbreviated "ITW" | | Founded | 1912, Chicago, Illinois. Incorporated 1915 (Form 10-K FY2025) | | Jurisdiction of incorporation | Delaware, USA (Form 10-K FY2025) | | IRS Employer ID | 36-1258310 | | Headquarters | 155 Harlem Avenue, Glenview, Illinois 60025, USA. Tel. (847) 724-7500 | | Exchange / ticker | New York Stock Exchange: ITW (common stock) | | Other listed securities (NYSE) | Euro notes: 0.625% due 2027 (ITW27); 3.250% due 2028 (ITW28); 2.125% due 2030 (ITW30); 1.00% due 2031 (ITW31); 3.375% due 2032 (ITW32); 3.00% due 2034 (ITW34) | | ISIN / CUSIP | US4523081093 / 452308109 | | Fiscal year end | 31 December | | Index membership | S&P 500 constituent. Fortune 300 company (company description, 2026) | ### Scale and organisation | Item | Detail | |---|---| | Employees (latest) | About 43,000 at 31 Dec 2025; about 16,000 in the U.S. (Form 10-K FY2025) | | Employee trend | About 46,000 (FY2022 release); about 45,000 (FY2023); about 44,000 (FY2024 release); about 43,000 (FY2025). This is a steady decline driven by 80/20 simplification and productivity, not by revenue contraction | | Organisation | 88 divisions in 49 countries; about 410 plants and office facilities (Form 10-K FY2025) | | Auditor | Deloitte & Touche LLP. Ratification proposed for FY2026 (2026 Proxy) | | Holders of record | About 3,957 at 31 Jan 2026 | | Website | www.itw.com / investor.itw.com | ### Market data | Item | Detail | |---|---| | Shares outstanding | 288.2 million at 31 Jan 2026 (Form 10-K). About 284 million estimated at 30 Jun 2026, after 4.3 million shares were repurchased in H1 2026 (10-Q Q2 FY2026; derived) | | Market capitalisation (current) | About $82 billion. Basis: share price of roughly $288–$295 (5 Aug 2026 close $295.06; early-September 2026 dividend yield of 2.39% implies about $288) × about 284 million shares | | Market cap at 31 Dec 2025 | About $71 billion (2026 Proxy) | | Market cap discrepancies | Third-party aggregators show $71bn–$85bn depending on date. Live verification is recommended | | 52-week range | $238.82 – $303.16 (as of Aug 2026, aggregator data) | Illinois Tool Works is a 114-year-old, Glenview-based multi-industrial manufacturer with $16.0 billion of FY2025 revenue across seven segments: - Automotive OEM - Food Equipment - Test & Measurement and Electronics - Welding - Polymers & Fluids - Construction Products - Specialty Products ITW does not compete on scale or vertical integration. Its edge is a proprietary operating system, the "ITW Business Model," built on three elements: - **80/20 Front-to-Back management**, which concentrates resources on the largest, most profitable customers and products. - **Customer-Back Innovation (CBI)**, which develops products from customer pain points rather than from a central R&D lab. **A decentralised, entrepreneurial culture:** of 88 scaled-up divisions. Since launching its Enterprise Strategy in late 2012, ITW has lifted operating margin from 15.9% to 26.3% and after-tax ROIC from 14.5% to 29.3%. It has done this while shrinking revenue through divestiture of commoditised businesses (2026 Proxy). The "Next Phase" (2024–2030) pivots the agenda from margin expansion to sustained 4%+ organic growth, powered by a 3%+ CBI revenue yield. ITW is a Dividend King, with 63 consecutive annual dividend increases. --- ### Company's own description (Form 10-K FY2025, paraphrased) ITW describes itself as a global manufacturer of a diversified range of industrial products and equipment, organised into 88 divisions operating in 49 countries. Its seven reportable segments are grouped by similar product offerings and end markets. Products are distributed mainly direct to industrial manufacturers and through independent distributors. Backlog is not considered significant because delivery periods are short and inventory turns quickly. The company names its core competitive advantage as the ITW Business Model: - 80/20 Front-to-Back process - Customer-Back Innovation - Decentralised entrepreneurial culture Primary raw materials are steel, resins and chemicals, sourced from numerous commercial suppliers. ### Business model | Revenue type | Characterisation | Evidence | |---|---|---| | Product sales: consumables | Majority of revenue. Welding filler metals; Polymers & Fluids chemicals; fasteners; Hi-Cone carriers; marking inks; test consumables; contamination-control wipes | Segment product lists (10-K FY2025) | | Product sales: capital equipment | Welding power sources; food equipment; test systems (Instron, MTS); electronic assembly equipment; line automation | Segment product lists (10-K FY2025) | | Services | Food Equipment service, maintenance and repair (service organic growth +2.8% FY2025, +4.8% FY2024); aftermarket service in Test & Measurement | 10-K FY2025 Food Equipment discussion | | Software / subscription | Test & measurement software is embedded with equipment. Not reported separately | Not publicly disclosed | | Licensing | Not material / not disclosed | Not publicly disclosed | ITW's model rests on niche leadership in fragmented, technically demanding markets. Its businesses typically hold strong positions in specialised applications where: - the product is a small share of the customer's total cost but critical to performance (e.g., an automotive fastener, a weld wire, a test frame); and - differentiation comes from engineering, application know-how, brand and service. The 80/20 discipline continually prunes low-value SKUs and customers through Product Line Simplification (PLS). PLS deliberately reduced organic revenue by about 60 basis points in FY2024, about 60 bps in FY2025, and about 60 bps in H1 FY2026, in exchange for structurally higher margins (10-K FY2025; 10-Q Q2 FY2026). **Revenue model mix.** ITW does not report a formal product/service/subscription split. The analyst characterisation is: ### Value-chain position ITW sits as a Tier-1/Tier-2 component supplier (Automotive OEM, Specialty appliance components) and as an OEM of branded equipment and consumables (Welding, Food Equipment, Test & Measurement, Construction Products, Polymers & Fluids). It typically manufactures "in the market, for the market." This localisation was cited in FY2025 as the reason ITW could largely offset U.S. tariff costs through pricing and supply-chain actions (FY2025 release; 10-K FY2025). ### Customer types and end markets | Segment | Primary end markets (10-K FY2025) | Customer type | |---|---|---| | Automotive OEM | Automotive OEMs and tiers | Global and Chinese OEMs; Tier-1 suppliers | | Food Equipment | Food service, food retail, food institutional/restaurant | Restaurant chains, independents, institutions (healthcare, education), supermarkets | | Test & Measurement and Electronics | Electronics/semiconductor, general industrial, auto OEM/tiers, energy, industrial capital goods, consumer durables | R&D labs, quality labs, semiconductor fabs, electronics assemblers | | Welding | General industrial (fabrication, shipbuilding), construction, energy, MRO, capital goods, auto | Fabricators, contractors, OEMs; heavily via distributors | | Polymers & Fluids | Automotive aftermarket, general industrial, MRO | Retail auto-care, body shops, industrial maintenance | | Construction Products | Residential construction, renovation/remodel, commercial construction | Contractors, truss fabricators, big-box retail | | Specialty Products | Food and beverage, consumer durables, airlines, general industrial, capital goods, printing/publishing | Beverage packers, appliance OEMs, airports/airlines, packaging converters | ### Independent characterisation ITW is best understood as a portfolio of about 88 mid-sized, high-return niche franchises bound together by a common management system. Corporate allocates capital. Divisions run the business. Strengths of this structure: - A low-capital-intensity, cash-generative model. Capex was 2.6% of revenue in FY2025 ($419M on $16,044M), and after-tax ROIC is about 29–31%. - Demand is diversified across consumer, industrial and capex cycles. Weaknesses of this structure: - Organic growth has historically been modest (FY2023–FY2025 averaged roughly 0–2%). - PLS creates a built-in headwind to reported growth. - The company has unusually high exposure to Detroit-3 and European auto content, short-cycle construction, and the semiconductor capex cycle. The FY2026 data, with Q2 organic growth of +4.5% and double-digit growth in Welding and Test & Measurement, is the first meaningful evidence that the CBI-driven growth pivot may be gaining traction.

Dell Technologies is the world's largest branded server vendor by revenue and the third-largest personal computer vendor, and it is now the principal listed proxy for the migration of artificial-intelligence infrastructure from hyperscale cloud into enterprise, sovereign and neocloud data centres. Two reporting segments — Infrastructure Solutions Group and Client Solutions Group — generated $113.5bn of revenue in FY2026, and the business is running at an annualised revenue rate above $190bn in FY2027 on the strength of AI-optimised server demand. Dell's structural advantages are a direct-plus-channel go-to-market reaching customers in more than 170 countries, a supply chain that can integrate, liquid-cool and deploy rack-scale GPU systems at volume, an installed base served by a global support organisation, and a captive financing arm. Its structural constraints are thin hardware gross margins, a negative book equity position, high customer concentration in AI, and dependence on component suppliers whose pricing power currently exceeds its own. --- ### The company's own description In its FY2026 Form 10-K the Company describes itself as "a leader in the global technology industry focused on providing broad and innovative technology solutions for the data and artificial intelligence ('AI') era," with solutions that "range from client devices and peripherals to infrastructure solutions across servers, networking, and storage." It states that it designs, deploys and supports "secure, integrated solutions that extend from the edge to the core to the cloud," delivering "AI-optimized, software-defined, and cloud native infrastructure solutions across a broad partner ecosystem." The stated vision is "to become the most essential technology partner," executed by "leveraging our strengths to extend our leadership positions and capture new growth," anchored in a corporate purpose "to create technologies that drive human progress." ### Independent characterisation Dell is, at its economic core, a high-velocity systems integrator and distributor of other companies' silicon. It does not manufacture processors, GPUs, memory or flash; it buys them, engineers systems and racks around them, and monetises the assembly, integration, deployment, financing and multi-year support that surrounds them. This is a low-gross-margin, high-asset-turnover, negative-working-capital business model. In FY2026 consolidated gross margin was 20.0% and operating margin 7.2%, while asset turnover was approximately 1.25x and the current ratio 0.91 — Dell is funded in substantial part by its suppliers through $33.6bn of accounts payable at year end, rising to $49.7bn by 31 July 2026. Three characteristics distinguish the current business from the Dell of five years ago: **First, mix has inverted.** ISG overtook CSG as the larger segment in FY2026 ($60.8bn versus $51.0bn) and by Q2 FY2027 was more than twice CSG's size ($31.8bn versus $15.0bn). Within ISG, AI-optimised servers — a product category that did not exist as a separate disclosure line until Q4 FY2026 — generated $24.7bn in FY2026 and $32.5bn in the first half of FY2027 alone. **Second, the revenue model has bifurcated.** Product revenue grew 27% in FY2026 to $90.4bn while services revenue declined 4% to $23.1bn. The services decline is a reporting artefact of the wind-down of VMware resale and the disposal of Secureworks rather than a deterioration in attach rates; ISG and CSG services both grew. Nevertheless, the services line — historically the margin ballast of the business — is now only 20.4% of revenue, down from 25.3% in FY2025, and 12.5% of revenue in Q2 FY2027. Mix is moving away from Dell's most profitable revenue. **Third, consumption models have become material.** The Dell Payment Solutions portfolio offers utility, subscription, as-a-Service, lease, loan and immediate-pay structures. Dell Financial Services funded $11.9bn of originations in FY2026 and carried a $14.3bn global financing-receivables portfolio at year end. Financing receivables grew by $6.4bn in the first half of FY2027 alone, a direct consequence of large AI transactions carrying longer payment terms — this is why adjusted free cash flow ($11.3bn in H1 FY2027) diverges so sharply from unadjusted free cash flow ($4.1bn). ### Value chain position, customers and end markets Dell occupies the systems-integration and channel layer between component suppliers (NVIDIA, AMD, Intel, Broadcom, Micron, Samsung, SK Hynix, Western Digital, Seagate) and end customers. Manufacturing is a hybrid: Dell owns plants in the United States, Malaysia, China, Brazil, India, Poland and Ireland, and also uses contract manufacturers, principally in Asia, purchasing components and on-selling them to those manufacturers — an arrangement that generates large non-trade receivables and is disclosed as a credit-concentration risk. Customer segments are large global and national enterprises, government agencies and public institutions, educational institutions, healthcare organisations, small and medium businesses, and consumers. In FY2026 approximately 40% of net revenue was generated through channels other than the direct sales force — value-added resellers, systems integrators, distributors and retailers. Two customer cohorts now drive the growth narrative and both concentrate risk. The 10-K states plainly that AI solutions "have been purchased primarily by a small number of larger customers and cloud service providers," that large orders "may occur in some periods and not others," and that such transactions "may also involve larger amounts of credit or longer payment terms than have been typical for our business." Management has separately characterised the AI pipeline as a mix of "neocloud, sovereign and enterprise customers."

Siemens is Europe's largest industrial technology group and, on the evidence of its own fiscal 2025 accounts, one of the very few diversified industrials that has successfully converted a hardware conglomerate into a software-and-automation compounder without sacrificing scale. Revenue of €78.9 billion and net income of €10.4 billion in FY2025 sit alongside a €117 billion order backlog and a 42,400-strong patent estate. The company's structural advantage is the pairing of installed-base automation hardware — SIMATIC, SINAMICS, SENTRON, Trainguard — with a first-tier industrial software franchise built through Mentor Graphics, Altair and Dotmatics, monetized through the Siemens Xcelerator platform. The planned spin-off of Siemens Healthineers, scheduled for a shareholder vote in February 2027, will strip roughly €23 billion of revenue but leave a more focused, higher-multiple portfolio of Digital Industries, Smart Infrastructure and Mobility. The strategic bet is explicit: industrial AI, electrification of data centres, and doubling digital revenue by 2030. --- ### What Siemens does — the company's own characterization Siemens describes itself in its FY2025 corporate boilerplate as a technology company focused on industry, infrastructure, mobility and healthcare, whose stated purpose is to create technology to transform the everyday. The formulation Siemens uses consistently across FY2025–FY2026 filings is that it combines the real and the digital worlds to help customers accelerate digital and sustainability transformations — making factories more efficient, cities more liveable, and transport more sustainable. Since FY2024 the company has appended a claim to leadership in industrial AI, positioning its domain knowledge as the differentiator that makes generative and predictive AI usable in physical industrial settings. ### Independent characterization Siemens is best understood not as a conglomerate but as three tightly coupled franchises plus a soon-to-be-detached fourth: **(a) An automation installed-base business with a software annuity attached (Digital Industries).** The economic engine here is the sale of controllers, drives, CNCs and industrial networking hardware into discrete and process manufacturing, followed by decades of engineering-software attach. Siemens' EDA business (formerly Mentor Graphics) and its PLM/simulation stack (NX, Teamcenter, Simcenter, now Altair) are genuinely tier-one franchises competing head-on with Dassault Systèmes, PTC, Cadence and Synopsys — not adjuncts to hardware. Digital Industries software revenue reached €1,790 million in Q3 FY2026 alone, up 16% year-over-year. **(b) A late-cycle electrification and buildings business riding a structural capex wave (Smart Infrastructure).** This is currently Siemens' best-performing franchise, with Q3 FY2026 orders of €8,002 million, up 40% nominally and 42% comparably, driven explicitly by large data-centre contracts in the US and Europe. Q3 FY2026 profit margin reached 20.0%. This is the segment most directly levered to the AI-infrastructure buildout. **(c) A long-cycle project and systems business with multi-decade service tails (Mobility).** Rolling stock, rail infrastructure, signalling and maintenance contracts. Order intake is lumpy — Q3 FY2026 included a €2.2 billion Swiss double-deck train order, a €2.0 billion UK extended-maintenance contract, and a €0.6 billion German battery-train service contract — but converts into decades of high-visibility service revenue. **(d) A consolidated but exiting medtech business (Siemens Healthineers).** 69% owned at Sept 30, 2025; reduced to approximately 67% subsequently. Siemens intends to distribute 30 percentage points of that stake directly to shareholders and, over the medium term, reduce the residual holding to a financial asset. **(e) A captive finance arm (Siemens Financial Services).** Total assets of €33,365 million at June 30, 2026. SFS both supports industrial sales through equipment and project finance and runs a proprietary debt and equity book. Its Q3 FY2026 EBT of €238 million included a €156 million gain from selling a UK equity stake — a reminder that SFS earnings are structurally lumpier than industrial earnings. ### Revenue model and mix | Mix disclosure | Latest data point | Source | |---|---|---| | Digital Industries software business revenue | €1,790m in Q3 FY2026 (36% of DI revenue that quarter) | Earnings Release Q3 FY2026 | | Smart Infrastructure service business revenue | €1,256m in Q3 FY2026 (20% of SI revenue) | Earnings Release Q3 FY2026 | | Mobility service business revenue | €573m in Q3 FY2026 (18% of Mobility revenue) | Earnings Release Q3 FY2026 | | Group digital business revenue | Grew approximately 19% in H1 FY2026; grew approximately 12% to €7.3bn in FY2023 | Q2 FY2026 press release; FY2023 press release | | FY2025 digital business revenue | n/v | Siemens Report FY2025 | | Full product vs. subscription vs. perpetual licence split | n/d | — | Siemens does not disclose a full product / service / subscription / licence split at group level. What is disclosed: The strategically important trend is Digital Industries' transition to a software-as-a-service model, which the Supervisory Board explicitly cited when extending Cedrik Neike's contract. SaaS conversion depresses reported revenue in transition years — a partial explanation for DI's FY2025 revenue decline of 4% against 8% order growth. ### Value chain position, customers and end markets Siemens sits at the specification and control layer of industrial value chains rather than at the commodity component layer. Its products are typically designed into customer plants, buildings, grids and rolling stock at the engineering stage, creating switching costs measured in years. **Customer types:** discrete manufacturers (automotive, electronics, machine building, aerospace); process industries (chemicals, pharmaceuticals, food and beverage, oil and gas, water); semiconductor and electronics designers (EDA); hyperscale and colocation data-centre operators; commercial and institutional building owners; electric utilities and distribution network operators; national and municipal rail operators and rolling-stock leasing companies; hospitals and diagnostic laboratories (via Healthineers); and life-sciences R&D organizations (via Dotmatics). **End markets served:** factory and process automation; industrial and engineering software; electrical distribution and low/medium-voltage electrification; data-centre power infrastructure; building automation, fire safety and security; e-mobility charging; grid software and automation; passenger and freight rail; medical imaging, diagnostics and radiation oncology; and equipment/project finance. **Geographic exposure (FY2025 revenue):** Europe/C.I.S./Africa/Middle East €36,933m (46.8%); Americas €25,758m (32.6%); Asia and Australia €16,224m (20.6%). Germany alone was €11,646m and the United States €22,097m — meaning the US is now Siemens' single largest country market by a factor of nearly two over its home market.

Eli Lilly is a research-based, vertically integrated pharmaceutical manufacturer that discovers, develops, manufactures and markets prescription medicines in a single reported business segment: human pharmaceutical products. Its commercial identity has been transformed since 2022 by the incretin class: tirzepatide, a dual GIP/GLP-1 receptor agonist, and from April 2026 orforglipron, an orally bioavailable non-peptide GLP-1 agonist. These assets have made Lilly the dominant player in the fastest-growing therapeutic category in pharmaceutical history, and have funded a step-change in capital deployment — more than $50 billion of announced U.S. manufacturing investment since 2020, $13.3 billion of FY2025 R&D spend, and more than a dozen acquisitions in 2026 alone. Around that core the company sustains four other franchises — oncology, immunology, neuroscience and legacy diabetes — and a direct-to-patient platform, LillyDirect. Lilly's central strategic bet is that obesity becomes a chronic-care category of unprecedented scale, and that it can own the supply, the pricing architecture and the next three generations of molecules within it. Eli Lilly and Company is, as of September 2026, the largest pharmaceutical company in the world by market capitalisation and the fastest-growing large-cap drug manufacturer by revenue. The company crossed the $1 trillion market-capitalisation threshold during 2025 — the first biopharmaceutical company ever to do so — on the strength of a single molecule, tirzepatide, commercialised under two brands (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnoea) that together generated $36.5 billion of revenue in FY2025. In April 2026 the company added the first small-molecule oral GLP-1 receptor agonist approved for obesity, Foundayo (orforglipron), to that franchise. --- ### The company's own characterisation Lilly describes itself in the FY2025 Form 10-K as a company that discovers, develops, manufactures and markets products in a single business segment — human pharmaceutical products — and states that most of the products it sells today were discovered or developed by its own scientists, with long-term success depending on the ability to continually discover or acquire, develop and commercialise innovative medicines. It manufactures and distributes through facilities in the United States (including Puerto Rico) and in Europe and Asia, and sells in approximately 105 countries. In its standard corporate boilerplate (Q2 2026 earnings release) Lilly positions itself as "a medicine company turning science into healing," with a 150-year history and scientific focus areas described as redefining diabetes care; treating obesity and curtailing its long-term complications; advancing the fight against Alzheimer's disease; addressing immune system disorders; and transforming difficult-to-treat cancers into manageable diseases. ### Independent characterisation Lilly is best understood today as three overlapping businesses operating under one P&L: **(a) The incretin platform (roughly 74% of FY2025 revenue).** Tirzepatide (Mounjaro + Zepbound) alone contributed $36.5 billion in FY2025, growing to a first-half 2026 run-rate of $27.7 billion across the two brands. Adding orforglipron (Foundayo, $98 million in its first partial quarter), legacy insulins, Trulicity and the Boehringer-partnered SGLT2/DPP-4 products, cardiometabolic health accounted for approximately $48.2 billion of FY2025 revenue. This is a volume business with unusually strong operating leverage: gross margin on the incretin portfolio has driven consolidated gross margin from 75.4% in FY2021 to 86.3% (non-GAAP) in Q2 2026, even as realised prices fell 13% year-on-year in that quarter. **(b) The diversified specialty portfolio (roughly 24% of FY2025 revenue).** Oncology ($9.4 billion), immunology ($5.2 billion) and neuroscience ($1.4 billion) constitute a conventional branded-pharma business with a normal mix of growth assets (Jaypirca, Ebglyss, Omvoh, Kisunla, Inluriyo) and mature or declining ones (Cyramza, Emgality, Taltz, Olumiant). Management has explicitly flagged this cluster as its diversification hedge: key-product revenue in immunology, oncology and neuroscience grew 121% year-on-year in Q2 2026. **(c) A capital-deployment engine.** With $16.8 billion of FY2025 operating cash flow rising to a $28.1 billion trailing-twelve-month figure at June 2026, Lilly has become one of the most acquisitive companies in the sector — at least thirteen acquisitions announced in 2026 through August — and the largest single builder of pharmaceutical manufacturing capacity in U.S. history. ### Revenue model and value-chain position Lilly's revenue is overwhelmingly product revenue. Approximately 93.5% of FY2025 revenue was product sales, with the balance (approximately $4.2 billion) collaboration and other revenue, principally from the Boehringer Ingelheim diabetes alliance, the Incyte relationship on Olumiant, royalty streams and sales-based milestones. There is no subscription revenue; "service" revenue is immaterial. The company occupies an unusually deep position in its value chain for a modern large-cap pharma: it manufactures its own active pharmaceutical ingredients, fills and finishes its own injectable devices, and, since January 2024, sells directly to patients through LillyDirect, bypassing parts of the traditional wholesaler-pharmacy-PBM chain for self-pay volumes. **Customer types and end-markets.** The direct customers are wholesalers and distributors (McKesson, Cencora, Cardinal Health in the U.S.), retail and specialty pharmacy chains, hospital systems, government purchasers (Medicare Part D plans, Medicaid programs, the Veterans Health Administration, and from 2026 the TrumpRx platform), managed-care organisations and pharmacy benefit managers, and — increasingly — patients paying cash through LillyDirect and affiliated telehealth partners. End-markets are obesity and metabolic disease, type 2 diabetes, oncology, immunology/inflammation, neurodegeneration and pain.

Dow Inc. is one of the world's largest commodity-to-specialty materials science companies and the largest chemical producer in North America by scale. Its economic engine is a globally integrated, feedstock-advantaged ethylene and propylene chain — anchored on the U.S. Gulf Coast and Western Canada — that converts low-cost natural-gas liquids into polyethylene, ethylene oxide derivatives, polyurethane intermediates, acrylics and silicones sold into packaging, infrastructure, mobility, consumer and industrial markets. Roughly half of revenue comes from Packaging & Specialty Plastics, making Dow's earnings highly levered to the global polyethylene margin cycle. After an extended 2023–2025 downcycle that drove a GAAP net loss of $2.4 billion in FY2025, a 50% dividend cut, three credit-rating downgrades and an AI-enabled restructuring ("Transform to Outperform"), Dow's 2026 earnings have rebounded sharply on Middle East supply disruption and self-help. A new CEO, Karen S. Carter, took over on 1 July 2026 to execute the turnaround. --- ### Company's own description In its FY2025 10-K and press-release boilerplate, Dow describes itself as one of the world's leading materials science companies serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications, operating manufacturing sites in 29 countries, employing ~34,600 people and generating ~$40 billion of 2025 sales. It frames its competitive edge around global breadth, asset integration and scale, focused innovation, and leading business positions. ### What Dow actually does — independent characterization Dow is fundamentally a vertically integrated petrochemical converter. It cracks ethane, propane and naphtha into ethylene and propylene (and co-products), then upgrades most of that molecule stream internally rather than selling it as merchant olefins. The integrated chain looks like this: 1. **Feedstocks & energy (Hydrocarbons & Energy business):** natural-gas liquids and naphtha purchased on index pricing; crackers in Freeport (TX), Plaquemine and St. Charles (LA), Fort Saskatchewan (AB), Terneuzen (NL), Böhlen (DE, slated for closure), Tarragona (ES), Bahía Blanca (AR), plus equity crackers via joint ventures (Sadara in Saudi Arabia, Thai JVs with SCG, Kuwait JVs). 2. **First-derivative conversion:** polyethylene (Dow is the world's leading PE producer by company claim), ethylene oxide/glycol, propylene oxide/glycol, chlor-alkali and vinyl (Europe, being rationalized), acrylic monomers, siloxanes. 3. **Downstream formulated/specialty products:** polyurethane systems, acrylic emulsions for coatings, silicone elastomers/fluids/resins, surfactants, amines, cellulose ethers, specialty elastomers and packaging resins. ### Business model and revenue model **Product sales dominate (~98% of revenue):** Revenue is overwhelmingly product sales under spot, contract (often formula-priced against feedstock/benchmarks) and long-term supply agreements. Q4 FY2025 cash flow references "advance payments received for low-carbon solutions and other long-term supply agreements," indicating a growing contracted component. **Technology licensing (~1–2%):** Dow licenses process technology (e.g., UNIPOL™ polyethylene process via Univation-heritage licensing, METEOR™ EO/EG process) and catalysts. **Insurance operations (Corporate segment):** Dow's captive insurance operations generated $701M of "Corporate" net sales in FY2025 (FY2024: $745M). **No meaningful subscription or service revenue:** ### Value chain position Upstream-to-midstream chemicals: Dow sits between oil & gas/NGL producers and converters/brand owners (film makers, packaging converters, paint formulators, foam producers, cable makers, personal-care formulators). It is a price-taker on feedstock and largely a price-taker on commodity polymers, with partial pricing power in specialties (silicones, acrylic binders, specialty elastomers). ### Customer types and end-markets Customers include flexible and rigid packaging converters, consumer packaged goods firms (directly and via converters), building & construction products manufacturers, paint and coatings formulators, automotive OEMs and Tier 1s, wire & cable manufacturers, appliance makers, personal-care and home-care formulators, pharma and food ingredient makers, energy/oilfield and industrial users, and electronics/semiconductor packaging firms (AI/advanced packaging materials showcased at SEMICON Taiwan, Sept 2026). End-markets by Dow's framing: packaging, infrastructure (building & construction, wire & cable, pipe), mobility (automotive, transportation), consumer (personal care, home care, electronics), industrial and energy.

| Field | Detail | |---|---| | Legal name | NOV Inc. | | Former names | National Oilwell Varco, Inc. (2005–2020); National-Oilwell, Inc. (pre-2005 predecessor) | | Website | www.nov.com (investor site: investors.nov.com) | | Country | United States | | Founding year | Corporate heritage traced to 1862 per company "160+ years" messaging. Some aggregators cite 1841 (discrepancy noted). Modern National-Oilwell formed in 1987; NOV formed by the 2005 merger of National-Oilwell and Varco International. | | Incorporation | Delaware, USA (IRS EIN 76-0475815) | | Headquarters | 10353 Richmond Avenue, Houston, Texas 77042-4103, USA; telephone (346) 223-3000 | | Primary listing | NYSE: NOV | | Secondary quotations | Xetra, Tradegate, Stuttgart and Munich (NO8); London Stock Exchange international line (0K58); Mexico BMV (NOV) | | ISIN / CUSIP | ISIN US62955J1034 / CUSIP 62955J103. Analyst knowledge; not re-verified against a filing in this research. | | SEC file number | 1-12317 | | Fiscal year end | 31 December | | Filer status | Large accelerated filer | | Auditor | Ernst & Young LLP, Houston (PCAOB ID 42), auditor since at least FY2021 per SEC data. ICFR attested. | | Chairman, President & CEO | Jose A. Bayardo (CEO since 1 January 2026) | | CFO | Rodney Reed | | Lead Independent Director | William Thomas | | Shares outstanding | 360,803,354 at 31 Dec 2025 (FY2025 10-K); about 358.9M per market data in August 2026 | | Market capitalization | About USD 7.3B (share price about USD 20.00 on 16 Sep 2026; 52-week range USD 12.23–21.93). Market data from AngelOne and Equibles. See Section 21 for a pricing anomaly noted on a London line in late September 2026. | | Enterprise value | About USD 8.75B (Benzinga, 31 Aug 2026; includes leases and minorities per vendor methodology) | | Regular dividend | USD 0.09 per quarter (raised 20% from USD 0.075 in early 2026) | | Countries served | 61 (FY2023 10-K); 59 (FY2024 10-K) | | Operating locations | 500+ across six continents (company description as reproduced by third parties; not re-verified) | The name supplied, "National Oilwell Varco Inc.", is the former name of the company. The entity profiled here is NOV Inc., an active, publicly listed company on the New York Stock Exchange (ticker NOV) with SEC CIK 0001021860. NOV Inc. is the continuing legal successor to National Oilwell Varco, Inc. and adopted the shortened name effective January 2021. The "Public company" classification supplied in the request is correct. | Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Employees (period end, headcount) | 27043 | 32307 | 33676 | 34010 | 31605 | Sources: 10-K Human Capital disclosures (FY2021–FY2024, as compiled by Macrotrends) and the NOV 2025 Sustainability Report (FY2025, as compiled by Tracenable). The FY2025 figure of 31,605 implies a reduction of about 7% year over year. This is consistent with the USD 100M+ cost-out program, which includes facility consolidations and product-line exits. Revelio Labs' modelled estimate (about 35,400) uses a different methodology and is disregarded. NOV is the world's largest independent, pure-play original equipment manufacturer and technology supplier to the upstream oil and gas industry. Its scale is unmatched in drilling rig equipment, drill pipe, drill bits, downhole tools and subsea flexible pipe. Rather than selling oilfield services on a per-well basis like SLB or Halliburton, NOV designs, manufactures, rents and supports the machinery and consumables that service companies, drilling contractors and operators use. It also monetizes an installed base of thousands of rigs through high-margin aftermarket spares, repair and digital services. The portfolio is split between a shorter-cycle, activity-driven segment (Energy Products and Services) and a longer-cycle, backlog-driven capital equipment segment (Energy Equipment). That mix gives NOV both near-term operating leverage to drilling activity and multi-year visibility, with USD 4.1B of backlog at June 2026. Growth vectors include offshore production (FPSO process systems, flexible pipe), automation and robotics, and international unconventionals. NOV also has optionality in geothermal, offshore wind installation vessels and carbon capture equipment. The balance sheet is near net-cash. --- ### Company's own description (paraphrased from the FY2023–FY2025 10-Ks) NOV describes itself as a leading independent equipment and technology provider to the global energy industry. Its stated mission is to deliver technology-driven solutions that improve the economics, efficiency, safety and environmental footprint of energy production. NOV says it applies its expertise and technology to support the transition toward more sustainable energy. Its strategic focus is on automation, predictive analytics and condition-based maintenance. The FY2025 10-K reiterates that NOV is focused on developing and commercializing products and services that lower the marginal cost and environmental footprint of energy production. The corporate tagline is that NOV "powers the industry that powers the world." ### Independent characterization NOV is best understood as an industrial capital-goods and consumables business levered to upstream oil and gas capex. It is not an oilfield-services company in the conventional sense. It has three economic engines: 1. **Consumables and rentals (short-cycle):** drill bits, drill pipe, downhole motors and tools, solids-control consumables, coiled tubing and wireline consumables, and composite pipe. Demand tracks rig counts and footage drilled, with a lag of weeks. 2. **Capital equipment (long-cycle):** rig packages (land and offshore), pressure pumping and intervention equipment, subsea flexible pipe, FPSO process modules and turret mooring systems, offshore cranes, and wind and cable-lay vessel equipment. These are booked into backlog and revenue is recognized over time, typically 6–36 months. 3. **Aftermarket and digital (installed-base annuity):** spares, repair, recertification, field service, upgrades, and software and data services (for example, wired drill pipe, rig control systems and remote monitoring). Aftermarket is the highest-margin stream in Energy Equipment. In Q1 2026 it was about 37% of that segment's revenue (USD 440M, down 12% year over year, per the Q1 2026 call). ### Revenue model mix | Revenue-stream proxy | Latest data point | Source | |---|---|---| | Energy Equipment capital equipment as % of segment revenue | 63% (Q4 2025) | Q4 2025 earnings call | | Energy Equipment aftermarket as % of segment revenue | about 37% (Q1 2026) | Q1 2026 earnings call | | Energy Products and Services | Mixture of product sales, rentals (for example, drilling motors), services (tubular inspection and coating, solids control) and digital subscriptions | FY2024 10-K / Q1 2024 10-Q | | Software and digital services | Growing for four consecutive quarters year over year to Q2 2026; absolute revenue not publicly disclosed | Q2 2026 call | NOV does not disclose a product versus service versus subscription versus licensing split in exactly those categories. It does disaggregate revenue by segment, destination and revenue stream in its 10-K revenue footnote. The proxies available are as follows: ### Value-chain position NOV is a Tier-1 OEM supplying the following customers: **Drilling contractors:** (for example, offshore jackup, semisub and drillship owners; land drillers): rig equipment, spares and service. **Oilfield service companies:** (pressure pumpers, coiled tubing and wireline operators, and the large integrated service companies): intervention equipment, consumables and rentals. - **Exploration and production operators**, including majors, NOCs and independents: drill pipe, bits, completion tools, subsea flexible pipe, production process systems and artificial lift. **Shipyards and EPC contractors:** rig packages, FPSO topside modules and offshore cranes. **Non-oilfield marine and industrial customers:** wind turbine installation vessel equipment, cable-lay systems, and (until April 2024) utility poles. ### End-markets | End-market | Segment exposure | Demand driver | |---|---|---| | North American land drilling and completions | Mainly EP&S | Rig count and frac spread count; E&P capital discipline | | International land (Middle East, Latin America including Argentina's Vaca Muerta, Asia) | Both | NOC capex; globalization of unconventionals (Saudi Arabia, UAE, Argentina) | | Offshore drilling | EE (rig aftermarket and upgrades) | Floater and jackup utilization and dayrates; reactivations | | Offshore production (deepwater, FPSO) | EE (flexible pipe, process systems, APL turrets) | Deepwater FIDs, especially Brazil (Petrobras) and Guyana | | Gas processing | EE (process systems) | LNG feed gas, gas monetization | | Renewables and energy transition | EE (wind installation vessels, cable-lay); EP&S (geothermal drilling tools) | Offshore wind build-out; geothermal drilling |

Huntsman is a mid-cap, globally diversified manufacturer of differentiated chemicals, organised around three segments. The largest is Polyurethanes, built on MDI (methylene diphenyl diisocyanate) and downstream systems, which accounts for roughly 65% of segment revenue. The other two are Performance Products, covering amines, maleic anhydride and catalysts, and Advanced Materials, covering epoxy, acrylic and polyurethane-based adhesives, composites and formulations for aerospace, power and industrial markets. Management's thesis since 2018 has been to move away from commodities and towards downstream, formulated and specified products tied to energy efficiency and lightweighting. Management has said these themes touch about two-thirds of sales. That repositioning was executed through divestitures (Venator, Chemical Intermediates & Surfactants, Textile Effects) and bolt-on acquisitions. It was then overwhelmed by a severe and prolonged chemical down-cycle. Adjusted EBITDA fell from USD 1.34 billion in FY2021 to USD 275 million in FY2025, the dividend was cut 65%, and the credit rating fell to sub-investment grade. The company's answer is an all-stock merger of equals with upstream chlor-alkali/epoxy producer Olin, which creates the vertically integrated "OlinHuntsman". --- ### Company self-description In its FY2025 earnings release (Feb 2026), Huntsman describes itself as a publicly traded global manufacturer and marketer of differentiated and specialty chemicals. It reported roughly USD 6 billion of 2025 revenue from continuing operations and sells thousands of chemical products worldwide to manufacturers serving consumer and industrial end markets [V]. The 10-K for FY2025 (filed February 2026) frames the business across three reportable segments: Polyurethanes, Performance Products and Advanced Materials. ### Independent characterisation Huntsman is best understood as a mid-stream to downstream chemical converter with one large semi-commoditised profit pool (MDI) and two smaller specialty franchises. The three businesses have different economics: **Polyurethanes (≈65% of FY2025 segment revenue):** is a scale business anchored by MDI production at Geismar (Louisiana, USA), Rotterdam (Netherlands) and Caojing (Shanghai, China, through joint ventures). Huntsman's strategy is to push as much MDI as possible into "differentiated" downstream systems: spray-foam insulation (Huntsman Building Solutions), automotive foams and composites, TPU elastomers, and footwear and furniture systems. These systems carry better and stickier margins than component MDI. Even so, segment profitability tracks the global MDI supply/demand balance. That balance has been structurally weakened by Chinese capacity additions, led by Wanhua. **Performance Products (≈17%):** makes amines (ethyleneamines, polyetheramines sold as JEFFAMINE), catalysts, carbonates and maleic anhydride. It is US-centred, with key sites on the Texas/Louisiana Gulf Coast plus Petfurdo in Hungary. Its end markets are coatings, composites, fuels and lubricants, agriculture, construction and electronics. The European maleic anhydride plant at Moers (Germany) was closed in 2025. **Advanced Materials (≈18%):** is the highest-quality franchise. It includes the ARALDITE adhesives and epoxy systems heritage, inherited from Ciba via Vantico, and serves aerospace, power transmission and distribution, automotive, electronics and industrial markets. It has consistently delivered segment adjusted EBITDA margins of about 16–20% and is the most resilient segment through the cycle. ### Revenue model | Revenue type | Assessment | |---|---| | Product sales | ~100% of revenue. Huntsman sells physical chemical products under spot, contract and formula-priced arrangements. | | Services | Immaterial. Technical service is bundled with product (e.g., spray-foam contractor training through Huntsman Building Solutions). | | Subscription | None | | Licensing / royalties | Immaterial and not separately disclosed | | Tolling / by-products | Disclosed as excluded from price/volume analysis. Small and not separately quantified. | | Equity income | Material in Polyurethanes, mainly from the minority-owned China MDI JV. Equity income in unconsolidated affiliates was USD 83M in FY2023, USD 44M in FY2024 and USD 4M in FY2025 [V]. | ### Value-chain position Upstream, Huntsman buys benzene, nitric acid/aniline inputs, chlorine/caustic, propylene oxide/polyols feedstocks, ethylene oxide/ethylene, natural gas and n-butane for maleic. It is not integrated into chlorine or epoxy building blocks (epichlorohydrin, bisphenol-A liquid epoxy resin). This gap is the core industrial logic of the Olin merger, since Olin is a leading chlor-alkali and epoxy producer. Downstream, Huntsman sells to formulators, OEMs and contractors. ### Customer types and end markets **Customers:** OEMs (automotive, aerospace, appliance, electrical equipment), formulators (coatings, adhesives, composites), construction product makers (insulation boards, spray-foam contractors, OSB/engineered wood), and industrial processors (footwear, furniture, lubricants, fuel additives). **End markets (management characterisation):** construction and insulation (the largest exposure), automotive and transportation, aerospace, power/electrical, industrial, consumer (footwear, furniture, bedding), energy (fuels and lubricants), and electronics. **Structural theme:** Management states that energy efficiency and lightweighting affect about two-thirds of total sales (FY2023 Q4 release, Feb 2024) [V].

Cummins is the world's largest independent manufacturer of commercial diesel and alternative-fuel engines. It has turned itself into a diversified "global power leader" whose earnings increasingly come from power generation rather than trucks. The company designs, makes, distributes and services: - engines from 2.8 to 95 litres; - generator sets, alternators and switchgear; - critical powertrain components (aftertreatment, turbochargers, fuel systems, axles and brakes from the 2022 Meritor acquisition); - zero-emission systems under the Accelera brand. Sales run through about 640 company-owned, JV and independent distributor locations and 13,000+ dealer locations in about 190 countries and territories (FY2025 10-K). In FY2025 revenue was USD 33.7 bn and EBITDA excluding special items was 17.4%. The investment case now rests on three drivers: 1. Data-centre standby and prime power, where management targets about USD 9 bn of revenue by 2030. 2. A North American truck recovery around the EPA 2027 NOx transition. 3. Shrinking losses at Accelera after the exit from electrolysers and fuel cells. Cummins is valued as a quality cyclical with a growing infrastructure-power growth component. --- **Company's own description (FY2025 10-K / press-release boilerplate, paraphrased).** Cummins calls itself a global power leader committed to "powering a more prosperous world." It operates five segments: Engine, Components, Distribution, Power Systems and Accelera. Together they offer: - diesel, alternative-fuel, electric and hybrid powertrains; - integrated power-generation systems; - critical components: aftertreatment, turbochargers, fuel systems, controls, transmissions, axles and brakes; - zero-emission technologies such as batteries and electric powertrains. The company frames its energy-transition strategy as "Destination Zero." It sells to original equipment manufacturers (OEMs), distributors, dealers and end-users. Its markets are heavy-duty truck, medium-duty truck and bus, light-duty automotive (principally the Stellantis Ram pickup), off-highway industrial and power generation. **Independent characterisation.** Cummins is a vertically integrated powertrain and power-systems franchise. Its economics are driven by an installed base of engines and generators that generates long-tail parts, service and rebuild revenue. Four structural features matter most. 1. **Independent engine-supplier position.** Cummins supplies engines to OEMs that do not build their own (PACCAR offers both its own MX and Cummins X15; Daimler Truck, International/Traton and others offer Cummins as an option or standard). It also supplies OEMs who outsource selected displacement classes. This independent position is both a moat (scale and technology) and a vulnerability, because OEMs can vertically integrate. 2. **Captive and allied channel.** The Distribution segment is the largest by revenue (USD 12.4 bn in FY2025). It turns a lumpy OEM business into recurring parts and service revenue: FY2025 parts USD 4,083 m plus service USD 1,798 m. 3. **Joint-venture leverage in China and India.** Equity, royalty and interest income from investees was USD 469 m in FY2025. Major contributors were Chongqing Cummins, Dongfeng Cummins, Beijing Foton Cummins, Tata Cummins and Komatsu Cummins Chile. This gives emerging-market exposure with limited consolidated capital. 4. **High-horsepower (HHP) power generation.** The QSK60, QSK78/HSK78 and QSK95 platforms, plus Centum-series gensets, are capacity-constrained assets. Hyperscale data-centre demand has re-rated these assets. Power Systems EBITDA margin rose from 18.4% (FY2024) to 22.7% (FY2025), 26.8% in H1-2026 and 29.5% in Q1-2026 (calc. from segment tables). **Revenue model mix.** Cummins does not report a product / service / subscription / licensing split. The proxy below uses FY2025 Distribution product-line data plus royalty income (FY2025 8-K Ex. 99). **Value-chain position.** Cummins is a Tier-1 and "Tier-0.5" supplier: it delivers complete powertrains with its own aftertreatment, turbo, fuel-system and electronic-control content. It is also a system integrator for power generation, selling engine, alternator, genset, paralleling switchgear, battery energy storage and microgrid controls. Finally, it is a channel owner in Distribution. **Customer types.** - Truck and bus OEMs. PACCAR, Daimler Truck, Traton/International, Stellantis (Ram) and Chinese OEMs via JVs are historically disclosed as major customers. - Off-highway OEMs: construction, mining, agriculture, rail, marine and oil & gas, including Komatsu. - Data-centre developers and hyperscalers, mostly via distributors and EPCs. - Utilities, commercial and industrial buyers, healthcare, telecom and defence. - Rental fleets, e.g., EquipmentShare (Sep 2026). **End-markets (FY2025 Engine segment sales by market, USD m):** - heavy-duty truck 3,489; - medium-duty truck and bus 3,613; - light-duty automotive 1,930; - off-highway 1,843.

Shell plc is a London-headquartered, UK-incorporated integrated energy company and one of the five Western "supermajors". Its economic engine is the world's largest portfolio of liquefied natural gas (LNG) supply and trading, a deepwater-weighted upstream business concentrated in Brazil, the US Gulf of America and Nigeria, and the world's largest branded fuel retail network, supported by a global trading and optimisation organisation that monetises volatility across crude, products, LNG, pipeline gas and power. Under CEO Wael Sawan (from 2023), Shell has pivoted from breadth to "value over volume": cutting structural costs by $5.8bn since 2022, exiting weaker chemicals, refining, onshore Nigeria and much of its renewables generation, and reallocating capital to LNG and long-life hydrocarbons — most visibly through the ~US$16.5bn enterprise-value acquisition of Canada's ARC Resources, completed 2 September 2026. Shareholder distributions of 40–50% of operating cash flow anchor the equity story. --- ### Company's own description (FY2025 Form 20-F, paraphrased) Shell describes itself as an international energy company engaged in the principal aspects of the energy and petrochemical industries, reporting through six segments: Integrated Gas (LNG and gas-to-liquids, including the marketing, trading and optimisation of LNG); Upstream (exploration and extraction of crude oil, natural gas and natural gas liquids); Marketing (Mobility, Lubricants, and Sectors & Decarbonisation); Chemicals and Products (chemical plants with their own marketing network, and refineries, together with oil products trading); Renewables and Energy Solutions (renewable power generation, marketing and trading of power and pipeline gas, and carbon credits); and Corporate (non-operating support activities) [V]. ### Independent characterisation Shell is best understood as three value pools bound together by a trading function: 1. **Resource businesses (Integrated Gas + Upstream).** In FY2025 these two segments generated $15.5bn of the Group's $18.8bn segment Adjusted Earnings before Corporate (≈82%) [V]. LNG is the distinctive franchise: Shell owns equity liquefaction (e.g., LNG Canada, Prelude FLNG, QGC, Nigeria LNG, Oman LNG, Qatar) and contracts large volumes of third-party offtake, which it optimises across a fleet of chartered LNG carriers. Upstream is concentrated in deepwater hubs and, after September 2026, Canada's Montney basin. 2. **Downstream customer businesses (Marketing + Chemicals & Products).** Marketing — fuel retail (~46,000 sites [R]), lubricants (global #1 by volume for many years [R]), aviation, marine and B2B fuels — is a steady earner ($4.0bn Adjusted Earnings in FY2025 [V]). Chemicals & Products is volatile: Products (refining plus oil trading) earned $2.2bn in FY2025 while Chemicals lost $1.1bn [V]. 3. **Power and low-carbon (Renewables & Energy Solutions).** Now explicitly a trading-led, asset-light business after sales of Sprng Energy (India) and the European onshore renewables portfolio in 2026; it earned only $172m in FY2025 [V]. **Revenue model mix.** Shell's revenue is overwhelmingly product sales (crude, gas, LNG, refined products, chemicals, power). Service, subscription and licensing revenues (e.g., Shell Catalysts & Technologies licensing, Shell Recharge charging fees, Shell Energy B2B contracts, fleet-card services) exist but are not separately disclosed and are immaterial to group revenue. Trading revenue is reported gross within revenue for physical trades; Shell does not disclose a standalone trading P&L, but signals trading contributions qualitatively in each quarterly update note. **Value chain position.** Fully integrated: exploration → production → liquefaction/GTL → shipping → regasification access → refining/chemicals → wholesale → retail, with trading interfaces at every link. **Customer types and end-markets.** Utilities and national gas buyers (LNG, notably in Asia and Europe); industrial and commercial B2B customers (fuels, lubricants, chemicals, power); airlines and shipping lines; retail motorists (≈30m+ customers a day historically [R]); and petrochemical converters.

Nouryon is a carve-out specialty chemicals platform built from the former specialty chemicals arm of AkzoNobel and owned since 2018 by Carlyle and GIC. It manufactures performance ingredients and process chemicals — surfactants, chelates, cellulose ethers, organic peroxides, metal alkyls, colloidal silica, expandable microspheres, chromatography media and pulp-bleaching chemicals — that customers use to make consumer and industrial products. Revenue is roughly $5.1bn, generated through roughly 63 plants and sold in more than 80 countries. Its competitive identity rests on a portfolio of global or regional leadership positions in niche, technically demanding chemistries (Expancel®, Kromasil®, Levasil®, Bermocoll®, Dissolvine®), long-term integrated supply contracts with pulp mills, and a disciplined, Axalta-style private-equity operating model under CEO Charlie Shaver. The investment debate centres on high adjusted EBITDA margins (~22.5%) and solid free cash flow set against heavy leverage (~5.0x), recurring IPO deferrals and cyclic exposure to polymer and pulp markets. --- ### What the company does Nouryon produces specialty and performance chemicals that enter customer formulations or manufacturing processes as functional ingredients, catalysts, initiators or process aids. The company itself characterises its output as "essential solutions" that customers use to manufacture everyday products in attractive end-markets, and it describes the business in its fact sheet as a global specialty chemicals leader operating in more than 80 countries with a portfolio of industry-leading brands (Nouryon company fact sheet). In its 2025 sustainability report the company frames growth as coming from innovating safer, more efficient and more sustainable chemistry for customers (Nouryon 2025 Sustainability Report release, 7 May 2026). ### Company's own description (paraphrased from latest public materials) Nouryon presents itself as a global specialty chemicals leader whose products are used in personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, building products, polymers, pulp and paper, oil and gas, and mining. Since the Q3 2024 reorganisation it organises around three segments — Consumer & Life Sciences, Performance Materials and Resource Solutions — and six business units (FY2024 results release, 7 Mar 2025). ### Independent characterisation Nouryon is best understood as a portfolio of ~30–40 mid-sized niche chemistry franchises sharing a common manufacturing, procurement and commercial backbone. Roughly three economic archetypes coexist: 1. **Formulated consumer ingredients** (surfactants, chelates, cellulose ethers, polymers for home & personal care, agro adjuvants, micronutrients): moderate cyclicality, sticky qualification, pricing tied to raw materials (ethylene oxide, fatty amines, cellulose). 2. **Polymer process chemistry** (organic peroxides, metal alkyls, PVC reactor additives): technically demanding, hazardous-materials handling acts as a barrier to entry; volumes track polyolefin and PVC operating rates, notably in China. 3. **Resource / pulp chemistry** (sodium chlorate, chlorine dioxide, hydrogen peroxide, mining and oilfield chemicals): energy-intensive and contract-based, with 10–15-year integrated "chemical island" supply agreements for pulp mills, especially in South America. ### Business and revenue model | Revenue model element | Estimated share | Comment | |---|---|---| | Product sales (B2B chemicals, spot + contract) | ~95%+ | Core model; priced per tonne, often with raw-material pass-through clauses | | Long-term integrated supply (pulp-mill "Integrated Manufacturing Model") | n/d (embedded in Resource Solutions) | 10–15-year agreements, e.g., Suzano (15-year, 2022), Metsä Fibre (2021), Arauco MAPA (2023), Bracell (2021) | | Technology licensing | Small, n/d | e.g., CiD PVC technology license in China (Jul 2021); SulNOx fuel additive licensing (trade press) | | Services / subscription | Negligible | Digital tools (My Nouryon portal; BeautyCreations™ AI formulation tool) support sales but are not separately monetised (n/d) | ### Value chain position Nouryon sits mid-stream: it buys base chemicals and energy (ethylene, ethylene oxide, fatty raw materials, salt/chlor-alkali derivatives — some from sister company Nobian — cellulose, aluminium, electricity), converts them into functional intermediates, and sells to formulators and manufacturers (consumer goods companies, paint makers, polymer producers, pulp mills, agrochemical formulators, pharma manufacturers). Distribution partners include IMCD and Brenntag Specialties for selected regions and lines. ### Customer types and end-markets | End-market cluster | Representative products | Representative named customers/partners (public) | |---|---|---| | Home & personal care | Surfactants, chelates (Dissolvine®), polymers, CMC, Structure® starches, Armocare® | Henkel Consumer Brands (2025 sustainability award) | | Agriculture & food | Adjuvants (Adsee®), micronutrients (HBED, EDDHA), ADOB fertilizers, food-grade ingredients | n/d | | Pharma & life sciences | Kromasil® chromatography media (peptide/GLP-1 purification) | n/d | | Paints, coatings & inks | Bermocoll® cellulose ethers, Expancel® microspheres, rheology modifiers | n/d | | Polymers | Organic peroxides, metal alkyls (TEAL, MMAO), PVC additives, recycled-PP restoration | Petro Rabigh (2024 supplier award) | | Pulp, paper & packaging | Sodium chlorate, chlorine dioxide plants, hydrogen peroxide, Expancel® for paperboard | Suzano, Arauco, Metsä Fibre, Bracell | | Oil, gas & mining | Demulsifiers, collectors, oilfield surfactants | n/d | | Building & infrastructure | Asphalt additives, cellulose ethers, colloidal silica | Brenntag (US asphalt distribution) | | Electronics, catalysts, batteries | Levasil® colloidal silica, high-purity metalorganics | n/d |

3M is a US-based diversified industrial technology company that turns a shared base of materials science (adhesives, abrasives, films, nonwovens, ceramics, optics and filtration) into tens of thousands of products for industrial, safety, transportation, electronics and consumer markets. After the April 2024 spin-off of Solventum and the completion of its exit from PFAS manufacturing at the end of 2025, it is a smaller, more focused company with about USD 25 billion of sales, 108 manufacturing sites and roughly 60,500 employees. Under Chairman and CEO William Brown, who joined in May 2024, the investment case has shifted from managing legal liabilities to operational self-help: faster new-product output, better service levels, footprint simplification and portfolio pruning. Adjusted operating margin has risen from 21.4% in FY2024 to 23.4% in FY2025, with a target of about 25% by 2027. Legacy PFAS and Combat Arms payment obligations still absorb a large share of cash flow and remain the main risk. --- **Company's own description.** The FY2025 10-K describes 3M as "a diversified technology company with a global presence" in three businesses: Safety and Industrial, Transportation and Electronics, and Consumer. It says most products draw on expertise in product development, manufacturing and marketing and face competition from other technology-oriented companies. In press releases the company describes itself as applying science to create customer-focused solutions, using diverse technology platforms, a global footprint and operational excellence. **Independent characterisation.** 3M is best understood as a materials-science platform company with a very wide catalogue, not as a classic conglomerate of unrelated businesses. A common set of core technologies (the company cites 49 technology platforms, per the 3M India FY2025-26 annual report) is recombined into products across unrelated end-markets. That gives 3M high gross margins and specification-based stickiness with customers, but it also creates complexity: tens of thousands of SKUs, more than a hundred plants, and a history of weak service performance. Current management is trying to keep the technology advantage while removing the complexity cost. **Business model.** 3M designs, manufactures and sells physical products. Revenue comes overwhelmingly from product sales. The company does not disclose a product, service, subscription or licensing split, and services and royalties are not material at group level (split not publicly disclosed). There is modest post-separation income from supply and transition-service agreements with Solventum, reported in Corporate and Other (USD 372 million of sales in FY2025). **Revenue model features.** - A large share of sales is consumable or repeat-purchase product (abrasives, tapes, respirators, filters, cleaning products, stationery), giving a recurring demand profile without contractual subscriptions. - Many industrial and transportation products are "specified in" to a customer design (for example an automotive platform or an electronic device), which locks in volume for the life of the programme. - Pricing is list-price based with distributor and retailer discounts. Specific pricing is not publicly disclosed. **Value chain position.** 3M sits mostly in the middle of the chain as a maker of engineered materials and components (tier-two or tier-three supplier to OEMs), and at the end of the chain as a branded finished-goods supplier in safety and consumer products. It is partly vertically integrated in key inputs such as mineral granules, some resins, films and adhesives. **Distribution.** Products are sold directly to users and through e-commerce and traditional wholesalers, retailers, jobbers, distributors and dealers (FY2025 10-K). Industrial sales depend heavily on distributors; consumer sales are concentrated in large retailers and online marketplaces. Management has a commercial-excellence programme aimed at improving channel performance. **Customer types and end-markets.** About 56% of FY2025 revenue came from outside the United States (FY2025 10-K, Item 1A).

Caterpillar Inc. was founded in 1925 through the merger of Holt Manufacturing Company and C.L. Best Tractor Co. and is incorporated in Delaware with global headquarters in Irving, Texas. The company operates as a publicly traded corporation on the New York Stock Exchange and maintains manufacturing, sales, and service operations across more than 190 countries. Within the heavy equipment and utility vehicles market, Caterpillar organizes its business into three primary segments — Construction Industries, Resource Industries, and Energy & Transportation — each of which directly addresses demand for large-scale machinery, off-highway vehicles, and utility-grade equipment deployed in construction, mining, quarrying, and infrastructure development worldwide. Caterpillar's core product portfolio in the heavy equipment and utility vehicles market spans crawler and wheel dozers, hydraulic excavators, motor graders, articulated and off-highway trucks, wheel loaders, backhoe loaders, skid steer loaders, compact track loaders, and telehandlers. The company also produces a broad range of utility vehicles including small dozers and compact construction equipment marketed under the Cat brand. Caterpillar competes directly with Komatsu, Volvo CE, Deere & Company, and CNH Industrial across these categories. Its dealer network — comprising approximately 160 dealers operating roughly 2,900 dealer locations globally — provides a distribution and aftermarket parts advantage that sustains machine uptime and customer retention at scale. Caterpillar's recent strategic direction in the heavy equipment and utility vehicles market centers on electrification, autonomy, and digital connectivity. The company has advanced its Cat® Command autonomous haulage and dozing systems, which are deployed commercially at mining and large construction sites. Caterpillar announced a partnership with Luck Stone in 2023 to deploy autonomous Cat 777 trucks at quarry operations, demonstrating commercial traction for autonomous utility vehicles beyond mining. The company also continues to invest in battery-electric and hydrogen-ready machine platforms, having unveiled the Cat 301.9 electric mini excavator and the Cat 320 electric excavator for urban construction applications, positioning itself ahead of tightening emissions regulations in Europe and North America. Caterpillar reported full-year 2024 revenues of $64.8 billion, with the Construction Industries segment generating approximately $21.6 billion and Resource Industries contributing approximately $11.5 billion, underscoring the company's dominant revenue base within heavy equipment end markets. Key customer segments include large mining operators such as BHP, Rio Tinto, and Freeport-McMoRan for high-tonnage haul trucks and dozers, as well as major civil infrastructure contractors and government-funded highway and utility construction programs globally. Caterpillar held an estimated 15–18% share of the global construction equipment market by revenue as of 2024, making it the largest single manufacturer in the sector by most industry measures